Favourites   Have ideas?  Sign in / Register

Positive:   Fiber ↓18.28   Membership ↓14.92   SaaS ↓14.92 «See more»   Teeth ↑14.92   Pets ↑28.62   Animals ↑28.62

Negative:   China company (fight) ↓2.72   Bad infrastructure  ↑4.16


Medicine segment

ABEO Abeona Therapeutics Inc. - Common Stock 7.56% up 6.72% 0.84 + Gene and cell, Medicine

+ My List
ABUS Arbutus Biopharma Corporation - Common Stock -2.63% down 8.78% -11.41 + Biopharma, Medicine, Hepatitis


Last highlighted: #ABUS SEC report: Arbutus Biopharma Corp Quarterly report [Sections 13 or 15(d)]
SEC Filing Form 10-Q filed by Arbutus Biopharma Corp -- SEC File Number 211148337
+ My List
ACER Acer Therapeutics Inc. - Common Stock 1.49% down 7.43% -5.94 + Medicine, Biopharma

+ My List
ACET Adicet Bio, Inc. - Common Stock 10.72% 10.72% 0 + Medicine, Cancer fight

+ My List
ACOR Acorda Therapeutics, Inc. - Common Stock 8.75% 8.75% 0 + Disease: Neurology/Alzheimer/Parkinson's, Medicine, Biotechnology


Last highlighted: Form 8-K: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain.. $ACOR https://t.co/pzylSpmKBK
+ My List
ACRS Aclaris Therapeutics, Inc. - Common Stock -7.95% down -7.63% -0.32 + Immunology, Biopharma, Medicine


Last highlighted: #ACRS SEC report: Aclaris Therapeutics, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Aclaris Therapeutics, Inc. -- SEC File Number
+ My List
ACRX AcelRx Pharmaceuticals, Inc. - Common Stock 6.42% down 7.34% -0.92 + Pharmaceutical , Medicine


Last highlighted: Form 8-K: Results of Operations and Financial Condition On January 14, 2021, AcelRx Pharmaceuticals issued a press re.. $ACRX https://t.co/85kZEX2ul8
+ My List
ADAP Adaptimmune Therapeutics plc - American Depositary Shares -6.54% up -9.85% 3.31 + Medicine, Cancer fight


Last highlighted: #ADAP SEC report: Adaptimmune Therapeutics PLC Statement of changes in beneficial ownership of securities
+ My List
ADMP Adamis Pharmaceuticals Corporation - Common Stock 10.48% up 9.52% 0.96 + Respiratory therapies / Pulmanory, Medicine, Biopharma

+ My List
ADMS Adamas Pharmaceuticals, Inc. - Common Stock -7.76% -7.76% 0 + Medicine, Disease: Neurology/Alzheimer/Parkinson's, Pharmaceutical

+ My List
ADTX ADiTx Therapeutics, Inc. - Common Stock -4.19% up -7.69% 3.5 + Immunology, RNA, Medicine

+ My List
ADXN Addex Therapeutics Ltd - American Depositary Shares -0.32% down 7.48% -7.8 + Medicine, Disease: Neurology/Alzheimer/Parkinson's, Pharmaceutical

+ My List
AEMD Aethlon Medical, Inc. - Common Stock 2.82% down 7.04% -4.22 + Health Devices, Medicine, Cancer fight

+ My List
AERI Aerie Pharmaceuticals, Inc. - Common Stock -10% down -8.52% -1.48 + Disease: Eye , Medicine, Pharmaceutical


Last highlighted: Alert [Press/News Current Report] / Form 8-K filed with the SEC $AERI AERIE PHARMACEUTICALS INC https://t.co/jhemDQoMVR
+ My List
AEZS Aeterna Zentaris Inc. - Common Stock 0 + Medicine, Disease: Endocrine disease, Biopharma

+ My List
AFIB Acutus Medical, Inc. - Common Stock -5.91% up -7.27% 1.36 + Medicine, Devices


Last highlighted: #AFIB SEC report: Acutus Medical, Inc. Statement of acquisition of beneficial ownership by individuals
SEC Filing Form SC 13G filed by Acutus Medical, Inc. -- SEC File Number 211102892
+ My List
AFMD Affimed N.V. - Common Stock 8.39% up 6.04% 2.35 + Immunology, Cancer fight, Medicine

+ My List
AGEN Agenus Inc. - Common Stock 9.87% 9.87% 0 + Cancer fight, Immunology, Medicine


Last highlighted: #AGEN SEC report: AGENUS INC Statement of changes in beneficial ownership of securities
+ My List
AGLE Aeglea BioTherapeutics, Inc. - Common Stock 7.33% 7.33% 0 + Medicine, Disease: Metabolic disorders


Last highlighted: #AGLE SEC report: Aeglea BioTherapeutics, Inc. Initial statement of beneficial ownership of securities
SEC Filing Form 3 filed by Aeglea BioTherapeutics, Inc. -- SEC File Number
+ My List
AGTC Applied Genetic Technologies Corporation - Common Stock -7.04% -7.04% 0 + Medicine, Gene and cell

+ My List
AHACW Alpha Healthcare Acquisition Corp. - Warrant 33.33% 33.33% 0 + Acquisitions/Investing, Medicine
- Bad infrastructure
+ My List
AHPI Allied Healthcare Products, Inc. - Common Stock 7.5% up 3.25% 4.25 + Medicine, Hardware, Respiratory therapies / Pulmanory

+ My List
AIH Aesthetic Medical International Holdings Group Ltd. - American Depositary Shares -2.57% up -8.64% 6.07 + Medicine, Surgery

+ My List
AIKI AIkido Pharma Inc. - Common Stock -6.8% up -8.74% 1.94 + Cancer fight, Pharmaceutical , Medicine


Last highlighted: #AIKI SEC report: AIkido Pharma Inc. Current report, item 8.01
SEC Filing Form 8-K filed by AIkido Pharma Inc. -- SEC File Number 211098058
+ My List
AKBA Akebia Therapeutics, Inc. - Common Stock -0.7% down 7.17% -7.87 + Medicine, Disease: Kidney


Last highlighted: #AKBA SEC report: Akebia Therapeutics, Inc. Quarterly report [Sections 13 or 15(d)]
SEC Filing Form 10-Q filed by Akebia Therapeutics, Inc. -- SEC File Number 211148438
+ My List
AKER Akers Biosciences Inc. - Common Stock -11% -11% 0 + Medicine, Pharmaceutical , Immunology, Cancer fight

+ My List
AKRO Akero Therapeutics, Inc. - Common Stock 7.28% up 4.12% 3.16 + Disease: Liver, Medicine


Last highlighted: #AKRO SEC report: Akero Therapeutics, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Akero Therapeutics, Inc. -- SEC File Number
+ My List
AKTX Akari Therapeutics Plc - American Depositary Shares 5.78% down 7.51% -1.73 + Medicine

+ My List
AKUS Akouos, Inc. - Common Stock 6.11% down 8.07% -1.96 + Gene and cell, Disease: Ear/Nose, Medicine

+ My List
ALDX Aldeyra Therapeutics, Inc. - Common Stock -7.14% up -8.24% 1.1 + Immunology, Medicine

+ My List
ALEC Alector, Inc. - Common Stock -14.7% down -14.19% -0.51 + Disease: Neurology/Alzheimer/Parkinson's, Immunology, Medicine


Last highlighted: #ALEC SEC report: Alector, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Alector, Inc. -- SEC File Number
+ My List
ALGS Aligos Therapeutics, Inc. - Common stock 1.3% down 7.89% -6.59 + Medicine, Hepatitis


Last highlighted: #ALGS SEC report: Aligos Therapeutics, Inc. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by Aligos Therapeutics, Inc. -- SEC File Number 211148130
+ My List
ALIM Alimera Sciences, Inc. - Common Stock -11.72% -11.72% 0 + Disease: Eye , Biopharma, Medicine

+ My List
ALLO Allogene Therapeutics, Inc. - Common Stock 7.03% up 6.77% 0.26 + Cancer fight, Gene and cell, Medicine

+ My List
ALPN Alpine Immune Sciences, Inc. - Common Stock 1.33% down 12.76% -11.43 + Medicine, Cancer fight

+ My List
ALRN Aileron Therapeutics, Inc. - Common Stock -8.7% -8.7% 0 + Cancer fight, Medicine, Biopharma

+ My List
ALT Altimmune, Inc. - Common Stock 5.31% down 7.15% -1.84 + Immunology, Biopharma, Medicine


Last highlighted: #ALT SEC report: Altimmune, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Altimmune, Inc. -- SEC File Number
+ My List
ALVR AlloVir, Inc. - Common Stock 6.05% down 7.51% -1.46 + Medicine

+ My List
ALXO ALX Oncology Holdings Inc. - Common Stock 4.51% down 7.01% -2.5 + Medicine, Cancer fight

+ My List
AMEH Apollo Medical Holdings, Inc. - Common Stock 6.17% down 8.56% -2.39 + Medicine, Healthcare


Last highlighted: #AMEH SEC report: Apollo Medical Holdings, Inc. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by Apollo Medical Holdings, Inc. -- SEC File Number 211148244
+ My List
AMRN Amarin Corporation plc - American Depositary Shares, each representing one Ordinary Share 3.94% down 7.61% -3.67 + Country: Ireland, Medicine, Disease: Cardiovascular

+ My List
AMTI Applied Molecular Transport Inc. - common stock -7.78% down -6.95% -0.83 + Biology, Medicine, Disease: Debilitating


Last highlighted: #AMTI SEC report: Applied Molecular Transport Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Applied Molecular Transport Inc. -- SEC File Number
+ My List
ANAB AnaptysBio, Inc. - Common Stock -5.77% up -10.5% 4.73 + Immunology, Cancer fight, Medicine

+ My List
ANCN Anchiano Therapeutics Ltd. - American Depositary Shares 0.00% 0 + Cancer fight, Biopharma, Medicine, Country: Israel

+ My List
ANIP ANI Pharmaceuticals, Inc. - Common Stock -8.53% -8.53% 0 + Generic, Pharmaceutical , Medicine

+ My List
ANIX Anixa Biosciences, Inc. - Common Stock 7.09% up 2.23% 4.86 + Cancer fight, Medicine, Immunology

+ My List
ANNX Annexon, Inc. - common stock 8.7% 8.7% 0 + Medicine, Disease: Neurology/Alzheimer/Parkinson's

+ My List
APDN Applied DNA Sciences, Inc. - Common Stock -6.73% up -7.26% 0.53 + Medicine, Gene and cell

+ My List
APEN Apollo Endosurgery, Inc. - Common Stock -6.94% up -7.44% 0.5 + Medicine, Equipment

+ My List
APM Aptorum Group Limited - Class A Ordinary Shares 5.99% down 8.99% -3 + Medicine

+ My List
APOP Cellect Biotechnology Ltd. - American Depositary Shares 6.02% down 7.57% -1.55 + Country: Israel, Cancer fight, Medicine

+ My List
APRE Aprea Therapeutics, Inc. - Common Stock 6.14% down 7.5% -1.36 + Medicine, Cancer fight


Last highlighted: Aprea Therapeutics Inc trading halted, news pending $APRE
+ My List
APTX Aptinyx Inc. - Common Stock 10.76% 10.76% 0 + Disease: Neurology/Alzheimer/Parkinson's, Medicine

+ My List
APVO Aptevo Therapeutics Inc. - Common Stock 6.47% down 8.18% -1.71 + Biotechnology, Medicine, Disease: Oncology, Immunology


Last highlighted: $APVTW [15s. delayed] filed form 8-K on May 27, 09:02:28: Item7.01: Regulation FD https://t.co/MpE2r05xab
+ My List
AQST Aquestive Therapeutics, Inc. - Common Stock 12.2% down 12.44% -0.24 + Medicine, Pharmaceutical

+ My List
ARAV Aravive, Inc. - Common Stock -0.26% -0.26% 0 + Medicine, Cancer fight

+ My List
ARAY Accuray Incorporated - Common Stock 0.00% 0 + Disease: Oncology, Medicine, Equipment, Manufacturing


Last highlighted: $ARAY 📜 Accuray Incorporated filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits https://t.co/48zqtD0zRx #healthcare
+ My List
ARCT Arcturus Therapeutics Holdings Inc. - Common Stock -6.38% up -7.24% 0.86 + Medicine

+ My List
ARDS Aridis Pharmaceuticals Inc. - Common Stock -1.74% down 7.2% -8.94 + Disease: Infectious, Pharmaceutical , Medicine

+ My List
ARDX Ardelyx, Inc. - Common Stock 0.69% up -8.28% 8.97 + Biology, Medicine


Last highlighted: Form 10-Q (quarterly report [sections 13 or 15(d)]) filed with the SEC $ARDX https://t.co/dIF5vLJfQt
+ My List
ARGX argenx SE - American Depositary Shares 1.29% down 9.97% -8.68 + Immunology, Medicine

+ My List
ARPO Aerpio Pharmaceuticals, Inc. - Common Stock -3.95% up -7.02% 3.07 + Medicine

+ My List
ARQT Arcutis Biotherapeutics, Inc. - Common stock -4.49% up -7.8% 3.31 + Skin, Medicine


Last highlighted: #ARQT SEC report: Arcutis Biotherapeutics, Inc. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by Arcutis Biotherapeutics, Inc. -- SEC File Number 211148286
+ My List
ARTL Artelo Biosciences, Inc. - Common Stock 0 + Biopharma, Medicine

+ My List
ARVN Arvinas, Inc. - Common Stock 1.57% up -7.19% 8.76 + Disease: Neuropsychiatric, Medicine, Disease: Oncology


Last highlighted: #ARVN SEC report: ARVINAS, INC. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by ARVINAS, INC. -- SEC File Number 211148061
+ My List
ARWR Arrowhead Pharmaceuticals, Inc. - Common Stock 0.27% 0.27% 0 + Biopharma, RNA, Medicine


Last highlighted: #ARWR SEC report: ARROWHEAD PHARMACEUTICALS, INC. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by ARROWHEAD PHARMACEUTICALS, INC. -- SEC File Number 211148133
+ My List
ASLN ASLAN Pharmaceuticals Limited - American Depositary Shares 2.71% down 8.14% -5.43 + Country: Singapore, Pharmaceutical , Biopharma, Immunology, Medicine


Last highlighted: $ASLN / ASLAN Pharmaceuticals files form 6-K https://t.co/rm8jqdBSsq
+ My List
ASMB Assembly Biosciences, Inc. - Common Stock 4.33% down 7.12% -2.79 + Disease: Infectious, Medicine, Biopharma

+ My List
ASYS Amtech Systems, Inc. - Common Stock 6.94% down 7.11% -0.17 + Semiconductor, Hardware, Medicine, Auto, Telecommunications , Mobile


Last highlighted: $ASYS / Amtech Systems files form 8-K - Financial Statements and Exhibits, Results of Operations and Financial Condition, Other Events - 8-K https://t.co/qugLTf9eMI
+ My List
ATEC Alphatec Holdings, Inc. - Common Stock 0.87% down 7.37% -6.5 + Medicine, Surgery


Last highlighted: #ATEC SEC report: Alphatec Holdings, Inc. Current report, items 1.01, 2.03, 3.02, and 9.01
SEC Filing Form 8-K filed by Alphatec Holdings, Inc. -- SEC File Number 211161008
+ My List
ATHE Alterity Therapeutics Limited - American Depositary Shares 1.55% 1.55% 0 + Disease: Neurology/Alzheimer/Parkinson's, Medicine


Last highlighted: $ATHE 📜 SEC Form 6-K filed by Alterity Therapeutics Limited https://t.co/sVJLLILdIZ #majorpharmaceuticals #healthcare
+ My List
ATHX Athersys, Inc. - Common Stock 8.05% 8.05% 0 + Medicine, Immunology, Gene and cell, Disease: Cardiovascular, Disease: Neurology/Alzheimer/Parkinson's

+ My List
ATNF 180 Life Sciences Corp. - Common Stock -5.38% up -7.92% 2.54 + Medicine


Last highlighted: #ATNF SEC report: 180 Life Sciences Corp. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by 180 Life Sciences Corp. -- SEC File Number
+ My List
ATNFW 180 Life Sciences Corp. - Warrant 4.55% down 8.18% -3.63 + Life Sciences, Medicine

+ My List
ATOS Atossa Therapeutics, Inc. - Common Stock -8.06% -8.06% 0 + Medicine

+ My List
ATRI Atrion Corporation - Common Stock -1.10% -1.10% 0 + Disease: Cardiovascular, Disease: Eye , Medicine, Devices

+ My List
ATXI Avenue Therapeutics, Inc. - Common Stock 8.82% up 6.47% 2.35 + Medicine


Last highlighted: $ATXI #NASDAQ 8-K - AVENUE THERAPEUTICS, INC. [B/A=0/0 - Bid/Ask Size=0/0 Volume=71,563 AverageVol=142,557 Outstanding=0] https://t.co/5J1Y10xWQb
+ My List
AUTL Autolus Therapeutics plc - American Depositary Shares 7.23% up 5.16% 2.07 + Country: Greate Britain, Gene and cell, Cancer fight, Medicine


Last highlighted: $AUTL Autolus Therapeutics to Report First Quarter 2021 Financial Results and Host Conference Call on May 6 https://t.co/Bswi1mwqgf
+ My List
AVCO Avalon GloboCare Corp. - Common Stock up -9.9% 9.9 + Cancer fight, Medicine, Immunology, Pharmaceutical


Last highlighted: #AVCO SEC report: Avalon GloboCare Corp. Current report, items 1.01 and 9.01
SEC Filing Form 8-K filed by Avalon GloboCare Corp. -- SEC File Number 211089336
+ My List
AVEO AVEO Pharmaceuticals, Inc. - Common Stock 1.25% down 8.6% -7.35 + Medicine, Disease: Oncology, Cancer fight


Last highlighted: #AVEO SEC report: AVEO PHARMACEUTICALS, INC. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by AVEO PHARMACEUTICALS, INC. -- SEC File Number 211148137
+ My List
AVGR Avinger, Inc. - Common Stock 0 + Medicine, Health Devices

+ My List
AVRO AVROBIO, Inc. - Common Stock 0.64% up -7.66% 8.3 + Gene and cell, Pain fight, Medicine

+ My List
AVXL Anavex Life Sciences Corp. - Common Stock -7.69% down -6.81% -0.88 + Gene and cell, Disease: Neurology/Alzheimer/Parkinson's, Medicine

+ My List
AWH Aspira Women's Health Inc. - Common Stock -2.07% -2.07% 0 + Cancer fight, Women Health, Medicine

+ My List
AXDX Accelerate Diagnostics, Inc. - Common Stock 1.08% down 20.56% -19.48 + Medicine, Blood


Last highlighted: #AXDX SEC report: Accelerate Diagnostics, Inc Current report, item 8.01
SEC Filing Form 8-K filed by Accelerate Diagnostics, Inc -- SEC File Number 211142195
+ My List
AXLA Axcella Health Inc. - Common Stock 3.75% down 8.63% -4.88 + Medicine, Biology, Disease: Metabolic disorders

+ My List
AXNX Axonics Modulation Technologies, Inc. - Common Stock 1.02% 1.02% 0 + Medicine, Disease: Neurology/Alzheimer/Parkinson's, Health Devices

+ My List
AYLA Ayala Pharmaceuticals, Inc. - Common Stock -18.73% -18.73% 0 + Medicine, Cancer fight

+ My List
AZRX AzurRx BioPharma, Inc. - Common Stock -6.92% up -9.3% 2.38 + Biopharma, Medicine, Disease: Gastrointestinal


Last highlighted: #AZRX SEC report: AzurRx BioPharma, Inc. Current report, item 5.02
SEC Filing Form 8-K filed by AzurRx BioPharma, Inc. -- SEC File Number 211083480
+ My List
AZYO Aziyo Biologics, Inc. - Class A Common Stock 6.64% down 7.23% -0.59 + Medicine, Regenerative

+ My List
BASI Bioanalytical Systems, Inc. - Common Stock down 15.52% -15.52 + Medicine, Analytics, Devices

+ My List
BCDA BioCardia, Inc. - Common Stock up -7.12% 7.12 + Medicine


Last highlighted: $BCDA lol BioCardia, Inc. Announces $10.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
+ My List
BCDAW BioCardia, Inc. - Warrant -12.06% -12.06% 0 + Medicine

+ My List
BCLI Brainstorm Cell Therapeutics Inc. - Common Stock -1.7% down 12.42% -14.12 + Medicine, Disease: Neurology/Alzheimer/Parkinson's

+ My List
BDSX Biodesix, Inc. - Common Stock 5.43% down 7.21% -1.78 + Biopharma, Medicine, Diagnosing, Disease: Lung


Last highlighted: A Form 8-K [Press/News Current Report] filing has been made with the SEC: $BDSX BIODESIX INC https://t.co/b5COJsaVls
+ My List
BEAM Beam Therapeutics Inc. - Common Stock 4.76% down 7.43% -2.67 + Medicine


Last highlighted: #BEAM SEC report: Beam Therapeutics Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Beam Therapeutics Inc. -- SEC File Number
+ My List
BEAT BioTelemetry, Inc. - Common Stock 0.00% 0 + Medicine, Health Devices, Software

+ My List
BIMI BOQI International Medical Inc. - Common Stock -9.8% -9.8% 0 + Country: China, Medicine, Pharmaceutical

+ My List
BIVI BioVie Inc. - Common stock -6.94% up -7.29% 0.35 + Medicine, Disease: Liver

+ My List
BLCM Bellicum Pharmaceuticals, Inc. - Common Stock 1.3% up -8.48% 9.78 + Biopharma, Medicine, Immunology


Last highlighted: #BLCM SEC report: BELLICUM PHARMACEUTICALS, INC Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by BELLICUM PHARMACEUTICALS, INC -- SEC File Number
+ My List
BLFS BioLife Solutions, Inc. - Common Stock -3.08% up -7.01% 3.93 + Medicine, Biology

+ My List
BLRX BioLineRx Ltd. - American Depositary Shares 7.17% 7.17% 0 + Medicine, Cancer fight

+ My List
BLU BELLUS Health Inc. - Common Shares -4.23% down 8.6% -12.83 + Country: Canada, Medicine, Hypersensitization

+ My List
BMRA Biomerica, Inc. - Common Stock -7.27% -7.27% 0 + Medicine

+ My List
BNGO Bionano Genomics, Inc. - Common Stock -0.19% -0.19% 0 + Medicine, Cancer fight, Gene and cell


Last highlighted: Bionano Genomics Acquires Diagnostics Services Provider Lineagen, Inc. to Accelerate Clinical Adoption of Saphyr for Digital Cytogenetics https://t.co/Q8ywclbV2i
+ My List
BNGOW Bionano Genomics, Inc. - Warrant 2.74% down 7.31% -4.57 + Cancer fight, Medicine, Gene and cell

+ My List
BNR Burning Rock Biotech Limited - American Depositary Shares -8.11% -8.11% 0 + Country: China, Cancer fight, Medicine

+ My List
BNTC Benitec Biopharma Inc. - Common Stock 2.94% down 13.37% -10.43 + Biopharma, Biotechnology, RNA, Medicine, Gene and cell


Last highlighted: Form 8-K: Regulation FD Disclosure. On February 24, 2021, Benitec Biopharma issued a presentation on the results of the interim analysis.. $BNTC https://t.co/mayyXsnb9Q
+ My List
BNTX BioNTech SE - American Depositary Shares 3.06% down 11.04% -7.98 + Biotechnology, Immunology, Covid (fighting), Medicine


Last highlighted: #BNTX SEC report: BioNTech SE Report of foreign issuer [Rules 13a-16 and 15d-16]
SEC Filing Form 6-K filed by BioNTech SE -- SEC File Number 211142358
+ My List
BPTH Bio-Path Holdings, Inc. - Common Stock -8.64% up -8.8% 0.16 + Cancer fight, Medicine

+ My List
BSGM BioSig Technologies, Inc. - Common Stock -6.55% up -8.14% 1.59 + Medicine, Electrophysiology


Last highlighted: #BSGM SEC report: BioSig Technologies, Inc. Current report, items 7.01 and 9.01
SEC Filing Form 8-K filed by BioSig Technologies, Inc. -- SEC File Number 211087605
+ My List
BTAI BioXcel Therapeutics, Inc. - Common Stock -8.75% -8.75% 0 + Medicine, Immunology, Artificial Intelligence, Biopharma

+ My List
BVXV BiondVax Pharmaceuticals Ltd. - American Depositary Shares -1.49% down 8.87% -10.36 + Biopharma, Medicine, Disease: Infectious

+ My List
BWAY Brainsway Ltd. - American Depositary Shares 2.37% 2.37% 0 + Country: Israel, Medicine, Equipment


Last highlighted: $BWAY 📜 SEC Form 6-K filed by Brainsway Ltd. https://t.co/r2SWTQzJTE #healthcare
+ My List
BXRX Baudax Bio, Inc. - Common stock -10.58% up -12.5% 1.92 + Surgery, Medicine, Biopharma

+ My List
BYSI BeyondSpring, Inc. - Ordinary Shares -5.6% up -7.73% 2.13 + Cancer fight, Biopharma, Medicine, Immunology


Last highlighted: Form 6-K (report of foreign issuer [rules 13a-16 and 15d-16]) filed with the SEC $BYSI https://t.co/AH1YS5LVCR
+ My List
CABA Cabaletta Bio, Inc. - Common Stock 7.42% up 7.05% 0.37 + Gene and cell, Medicine, Immunology

+ My List
CALA Calithera Biosciences, Inc. - Common Stock -2.38% -2.38% 0 + Medicine, Cancer fight

+ My List
CAPR Capricor Therapeutics, Inc. - Common Stock 9.77% 9.77% 0 + Medicine

+ My List
CARA Cara Therapeutics, Inc. - Common Stock 8.08% 8.08% 0 + Medicine, Disease: Kidney, Disease: Liver, Skin, Dermatology


Last highlighted: Form 8-K: Regulation FD Disclosure. On April 29, 2021, Cara Therapeutics issued a press release announcing topline.. $CARA https://t.co/cUtiqqrXat
+ My List
CASI CASI Pharmaceuticals, Inc. - Common Stock -2.72% down 10.45% -13.17 + Medicine
- China company (fight)
+ My List
CATB Catabasis Pharmaceuticals, Inc. - Common Stock -7.27% -7.27% 0 + Medicine


Last highlighted: $AYTU 8k just out -- FDA news $CATB $NAOV The Company recently established a purchasing relationship with a U.S. supplier of Emergency Use Authorization (EUA) authorized antigen tests. Antigen tests rapidly detect the presence of the SARS-CoV-2 virus antigen via a nasopharyngeal
+ My List
CBIO Catalyst Biosciences, Inc. - Common Stock 18.01% up 17.3% 0.71 + Biopharma, Medicine


Last highlighted: #CBIO SEC report: CATALYST BIOSCIENCES, INC. Quarterly report [Sections 13 or 15(d)]
SEC Filing Form 10-Q filed by CATALYST BIOSCIENCES, INC. -- SEC File Number 211147291
+ My List
CCCC C4 Therapeutics, Inc. - Common Stock 7.41% down 7.48% -0.07 + Medicine, Disease: Proteins


Last highlighted: #CCCC SEC report: C4 Therapeutics, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by C4 Therapeutics, Inc. -- SEC File Number
+ My List
CCXI ChemoCentryx, Inc. - Common Stock -0.13% down 7.05% -7.18 + Biopharma, Cancer fight, Immunology, Medicine


Last highlighted: #CCXI SEC report: ChemoCentryx, Inc. Current report, items 7.01, 8.01, and 9.01
+ My List
CDAK Codiak BioSciences, Inc. - Common Stock -4.57% up -7.5% 2.93 + Medicine, Biopharma

+ My List
CDNA CareDx, Inc. - Common Stock -5.72% up -9.28% 3.56 + Medicine, Biopharma, Transplant


Last highlighted: #CDNA SEC report: CareDx, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by CareDx, Inc. -- SEC File Number
+ My List
CDTX Cidara Therapeutics, Inc. - Common Stock 7.5% 7.5% 0 + Disease: Infectious, Medicine


Last highlighted: #CDTX SEC report: Cidara Therapeutics, Inc. Initial statement of beneficial ownership of securities
SEC Filing Form 3 filed by Cidara Therapeutics, Inc. -- SEC File Number
+ My List
CDXC ChromaDex Corporation - Common Stock -4.32% down 20% -24.32 + Food, Medicine

+ My List
CDXS Codexis, Inc. - Common Stock -0.57% -0.57% 0 + Medicine, Gene and cell

+ My List
CELC Celcuity Inc. - Common Stock 4.65% down 9.24% -4.59 + Cancer fight, Medicine


Last highlighted: #CELC SEC report: Celcuity Inc. Statement of acquisition of beneficial ownership by individuals
SEC Filing Form SC 13G filed by Celcuity Inc. -- SEC File Number 211081754
+ My List
CEMI Chembio Diagnostics, Inc. - Common Stock 8.53% down 11.24% -2.71 + Disease: Infectious, Medicine, Detection and monitoring


Last highlighted: #CEMI SEC report: CHEMBIO DIAGNOSTICS, INC. Current report, items 8.01 and 9.01
SEC Filing Form 8-K filed by CHEMBIO DIAGNOSTICS, INC. -- SEC File Number 211102696
+ My List
CERC Cerecor Inc. - Common Stock 6.95% down 8.11% -1.16 + Medicine, Disease: Pediatric


Last highlighted: Alert [Press/News Current Report] / Form 8-K filed with the SEC $CERC Cerecor Inc https://t.co/GH20Cp1MEt
+ My List
CFMS Conformis, Inc. - Common Stock -1.11% down 7.23% -8.34 + Medicine, Health Devices, Implants

+ My List
CFRX ContraFect Corporation - Common Stock 5.19% down 9.09% -3.9 + Biology, Medicine, Disease: Infectious

+ My List
CGIX Cancer Genetics, Inc. - Common Stock -0.86% -0.86% 0 + Cancer fight, Medicine

+ My List
CHFS CHF Solutions, Inc. - Common Stock 1.54% 1.54% 0 + Medicine, Heart failure


Last highlighted: $CHFS 📜 SEC Form 8-K filed https://t.co/OdFsqevtuC #healthcare
+ My List
CHMA Chiasma, Inc. - Common Stock -6.86% -6.86% 0 + Biopharma, Medicine


Last highlighted: $AMYT 6-K Amryt Pharma (5 May, 8:45am) 📰 Amryt Pharma to Acquire Chiasma, Inc. to Further Strengthen Global Leadership in Rare and Orphan Diseases https://t.co/30R4PU1D1d #AMYT #6K #AmrytPharma #News
+ My List
CHNG Change Healthcare Inc. - Common Stock -6.55% up -8.59% 2.04 + Medicine, Software, Finance


Last highlighted: Alert [Press/News Current Report] / Form 8-K filed with the SEC $CHNG $CHNGU Change Healthcare Inc https://t.co/ScU2J5EvVC
+ My List
CKPT Checkpoint Therapeutics, Inc. - Common Stock -1.89% -1.89% 0 + Cancer fight, Medicine

+ My List
CLDX Celldex Therapeutics, Inc. - Common Stock 6.55% down 7.16% -0.61 + Cancer fight, Immunology, Medicine


Last highlighted: #CLDX SEC report: Celldex Therapeutics, Inc. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by Celldex Therapeutics, Inc. -- SEC File Number 211148052
+ My List
CLGN CollPlant Biotechnologies Ltd. - American Depositary Shares 8.08% up 3.09% 4.99 + Medicine, Regenerative

+ My List
CLLS Cellectis S.A. - American Depositary Shares 5.94% down 7.14% -1.2 + Biopharma, Medicine, Cancer fight

+ My List
CLPT ClearPoint Neuro Inc. - Common Stock 7.04% up 6.62% 0.42 + Medicine, Disease: Neurology/Alzheimer/Parkinson's

+ My List
CLRB Cellectar Biosciences, Inc. - Common Stock -7.41% up -9.26% 1.85 + Medicine, Biopharma, Cancer fight


Last highlighted: #CLRB SEC report: Cellectar Biosciences, Inc. Current report, items 7.01 and 9.01
SEC Filing Form 8-K filed by Cellectar Biosciences, Inc. -- SEC File Number 211087932
+ My List
CLSD Clearside Biomedical, Inc. - Common Stock -1.92% down 10.76% -12.68 + Disease: Eye , Medicine, Biopharma

+ My List
CLSN Celsion Corporation - Common Stock 7.84% up 3.92% 3.92 + Cancer fight, Medicine

+ My List
CMLF CM Life Sciences, Inc. - Class A Common Stock -5.55% -5.55% 0 + Acquisitions/Investing, Medicine


Last highlighted: #CMLF SEC report: CM Life Sciences, Inc. Current report, item 8.01
SEC Filing Form 8-K filed by CM Life Sciences, Inc. -- SEC File Number 211098448
+ My List
CMLFU CM Life Sciences, Inc. - Unit -6.24% -6.24% 0 + Acquisitions/Investing, Medicine

+ My List
CMLFW CM Life Sciences, Inc. - Warrant -11.14% -11.14% 0 + Medicine, Acquisitions/Investing


Last highlighted: @The_Hailestorm @AnthonyOhayon @DavidNLefkowitz I want to thank you and @The_Hailestorm for your comments on CMLFW which I can apply to the 10-Qs of my other spaqs and become more informed. So far, I have been lucky as all but one have done really well (sklz, dm, dkng, ipoe and a few others)
+ My List
CMPI Checkmate Pharmaceuticals, Inc. - Common Stock -8.75% -8.75% 0 + Cancer fight, Medicine, Pharmaceutical


Last highlighted: #CMPI SEC report: Checkmate Pharmaceuticals, Inc. Current report, items 7.01 and 9.01
SEC Filing Form 8-K filed by Checkmate Pharmaceuticals, Inc. -- SEC File Number 211142205
+ My List
CNCE Concert Pharmaceuticals, Inc. - Common Stock -1.45% down 8.83% -10.28 + Biopharma, Medicine

+ My List
CNST Constellation Pharmaceuticals, Inc. - Common Stock 65.42% down 65.56% -0.14 + Cancer fight, Medicine, Pharmaceutical

+ My List
CNTG Centogene N.V. - Common Shares 0.85% down 7.31% -6.46 + Gene and cell, Medicine


Last highlighted: #CNTG SEC report: Centogene N.V. Report of proposed sale of securities
SEC Filing Form 144 filed by Centogene N.V. -- SEC File Number 211084208
+ My List
COCP Cocrystal Pharma, Inc. - Common Stock 7.21% up 5.41% 1.8 + Medicine, Hepatitis, COVID, Covid (fighting)

+ My List
CPRX Catalyst Pharmaceuticals, Inc. - Common Stock 11% 11% 0 + Pharmaceutical , Medicine


Last highlighted: #CPRX SEC report: CATALYST PHARMACEUTICALS, INC. Initial statement of beneficial ownership of securities
SEC Filing Form 3 filed by CATALYST PHARMACEUTICALS, INC. -- SEC File Number
+ My List
CRBP Corbus Pharmaceuticals Holdings, Inc. - Common Stock -1.54% down 8.33% -9.87 + Cannabis, Medicine


Last highlighted: FORM 8-K [Press/News Current Report] recently SEC filed. $CRBP Corbus Pharmaceuticals Holdings, Inc https://t.co/pH8ys4gCNC
+ My List
CRDF Cardiff Oncology, Inc. - Common Stock -0.3% down 8.23% -8.53 + Cancer fight, Medicine


Last highlighted: #CRDF SEC report: Cardiff Oncology, Inc. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by Cardiff Oncology, Inc. -- SEC File Number 211148042
+ My List
CRIS Curis, Inc. - Common Stock 7.22% down 7.36% -0.14 + Cancer fight, Medicine

+ My List
CRNX Crinetics Pharmaceuticals, Inc. - Common Stock 13.22% 13.22% 0 + Pharmaceutical , Disease: Endocrine disease, Medicine


Last highlighted: #CRNX SEC report: Crinetics Pharmaceuticals, Inc. Automatic shelf registration statement of securities of well-known seasoned issuers
SEC Filing Form S-3ASR filed by Crinetics Pharmaceuticals, Inc. -- SEC File Number 211161145
+ My List
CRVS Corvus Pharmaceuticals, Inc. - Common Stock 36.4% down 57.02% -20.62 + Medicine, Immunology, Pharmaceutical

+ My List
CSTL Castle Biosciences, Inc. - Common stock -2.18% up -7.37% 5.19 + Cancer fight, Medicine

+ My List
CTSO Cytosorbents Corporation - Common Stock 2.14% down 8.84% -6.7 + Immunology, Medicine, Surgery


Last highlighted: #CTSO SEC report: Cytosorbents Corp Current report, items 8.01 and 9.01
SEC Filing Form 8-K filed by Cytosorbents Corp -- SEC File Number 211074173
+ My List
CTXR Citius Pharmaceuticals, Inc. - Common Stock -5.33% up -7.11% 1.78 + Pharmaceutical , Medicine


Last highlighted: #CTXR SEC report: Citius Pharmaceuticals, Inc. Notice of Effectiveness
SEC Filing Form EFFECT filed by Citius Pharmaceuticals, Inc. -- SEC File Number 211081579
+ My List
CTXRW Citius Pharmaceuticals, Inc. - Warrant up -10% 10 + Pharmaceutical , Medicine

+ My List
CVAC CureVac N.V. - Ordinary Shares -8.29% up -8.49% 0.2 + Country: Germany, RNA, Medicine, Biopharma

+ My List
CWBR CohBar, Inc. - Common Stock 0.00% 0 + Medicine


Last highlighted: $CWBR 📜 CohBar, Inc. filed SEC Form 8-K: Results Of Operations And Financial Condition, Financial Statements And Exhibits https://t.co/1PY77pNKfw #majorpharmaceuticals #healthcare
+ My List
CYCC Cyclacel Pharmaceuticals, Inc. - Common Stock -4.93% down 9.09% -14.02 + Biotechnology, Biopharma, Pharmaceutical , Medicine, Gene and cell
- Bad infrastructure
+ My List
CYCCP Cyclacel Pharmaceuticals, Inc. - 6% Convertible Preferred Stock 8.42% 8.42% 0 + Cancer fight, Medicine, Biopharma


Last highlighted: Filing Alert, FORM 8-K [Press/News Current Report] available. $CYCC $CYCCP #CyclacelPharmaceuticals, Inc. https://t.co/wcEcOgiN2c
+ My List
CYCN Cyclerion Therapeutics, Inc. - Common Stock 9.59% 9.59% 0 + Medicine, Disease: Central nervous system (CNS)

+ My List
CYTK Cytokinetics, Incorporated - Common Stock -1.47% -1.47% 0 + Medicine, Disease: Cardiovascular


Last highlighted: $CYTK 📜 Cytokinetics, Incorporated filed SEC Form 8-K: Other Events https://t.co/IRZWvqv3LN
+ My List
DBVT DBV Technologies S.A. - American Depositary Shares 6.88% down 8.01% -1.13 + Immunology, Biopharma, Medicine


Last highlighted: #DBVT SEC report: DBV Technologies S.A. Quarterly report [Sections 13 or 15(d)]
SEC Filing Form 10-Q filed by DBV Technologies S.A. -- SEC File Number 211136660
+ My List
DCTH Delcath Systems, Inc. - Common Stock 8.4% up 7.29% 1.11 + Cancer fight, Medicine, Disease: Liver


Last highlighted: #DCTH SEC report: DELCATH SYSTEMS, INC. Notice of Effectiveness
+ My List
DMAC DiaMedica Therapeutics Inc. - Common Stock -2% down 8.7% -10.7 + Biopharma, Disease: Kidney, Medicine, Disease: Acute ischemic stroke (AIS)

+ My List
DMTK DermTech, Inc. - Common Stock -8.57% down -8.41% -0.16 + Medicine, Cancer fight, Skin


Last highlighted: #DMTK SEC report: DermTech, Inc. Initial statement of beneficial ownership of securities
SEC Filing Form 3 filed by DermTech, Inc. -- SEC File Number
+ My List
DNLI Denali Therapeutics Inc. - Common Stock 6.09% down 7.25% -1.16 + Medicine, Disease: Neurology/Alzheimer/Parkinson's

+ My List
DRAD Digirad Corporation - Common Stock 0.00% 0 + Medicine, Hardware

+ My List
DRIO DarioHealth Corp. - Common Stock -0.08% up -8.62% 8.54 + Healthcare, Medicine, Health Devices


Last highlighted: #DRIO SEC report: DarioHealth Corp. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by DarioHealth Corp. -- SEC File Number
+ My List
DRNA Dicerna Pharmaceuticals, Inc. - Common Stock 1.42% 1.42% 0 + Biopharma, Pharmaceutical , RNA, Medicine


Last highlighted: $DRNA 📜 Dicerna Pharmaceuticals, Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits https://t.co/pVex4DfvFC 30s delayed.
+ My List
DRRX DURECT Corporation - Common Stock 7.32% up 5.69% 1.63 + Biopharma, Disease: Liver, Medicine


Last highlighted: $DRRX New Form 8-K for DURECT Corporation From our Stock News Alerts App
+ My List
DVAX Dynavax Technologies Corporation - Common Stock 5.54% down 7.75% -2.21 + Immunology, Biology, Biopharma, Medicine, Vaccines


Last highlighted: #DVAX SEC report: DYNAVAX TECHNOLOGIES CORP Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by DYNAVAX TECHNOLOGIES CORP -- SEC File Number
+ My List
DYAI Dyadic International, Inc. - Common Stock -7.12% up -7.29% 0.17 + Medicine, Biopharma, Pharmaceutical

+ My List
DYN Dyne Therapeutics, Inc. - Common Stock -0.86% -0.86% 0 + Gene and cell, Medicine


Last highlighted: #DYN SEC report: Dyne Therapeutics, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Dyne Therapeutics, Inc. -- SEC File Number
+ My List
DYNT Dynatronics Corporation - Common Stock 5.11% down 8.03% -2.92 + Health Devices, Healthcare, Medicine

+ My List
EAR Eargo, Inc. - Common Stock -1.83% down 9.78% -11.61 + Medicine, Health Devices

+ My List
EARS Auris Medical Holding Ltd. - Common Shares -0.32% -0.32% 0 + Medicine, Covid (fighting)


Last highlighted: #EARS SEC report: Auris Medical Holding Ltd. Report of foreign issuer [Rules 13a-16 and 15d-16]
SEC Filing Form 6-K filed by Auris Medical Holding Ltd. -- SEC File Number 211102795
+ My List
ECOR electroCore, Inc. - Common Stock 4% down 7% -3 + Disease: Metabolic disorders, Disease: Neurology/Alzheimer/Parkinson's, Medicine


Last highlighted: #ECOR SEC report: electroCore, Inc. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by electroCore, Inc. -- SEC File Number 211148266
+ My List
EDIT Editas Medicine, Inc. - Common Stock -3.38% down 7.96% -11.34 + Medicine, Gene and cell


Last highlighted: #EDIT SEC report: Editas Medicine, Inc. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by Editas Medicine, Inc. -- SEC File Number 211142329
+ My List
EDSA Edesa Biotech, Inc. - Common Shares 4.26% down 15.24% -10.98 + Medicine, Biopharma, Immunology

+ My List
EHTH eHealth, Inc. - Common Stock 6.27% down 8.08% -1.81 + Insuranse, Medicine


Last highlighted: #EHTH SEC report: eHealth, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by eHealth, Inc. -- SEC File Number
+ My List
EIGR Eiger BioPharmaceuticals, Inc. - Common Stock -9.14% -9.14% 0 + Medicine, Biopharma


Last highlighted: #EIGR SEC report: Eiger BioPharmaceuticals, Inc. Quarterly report [Sections 13 or 15(d)]
SEC Filing Form 10-Q filed by Eiger BioPharmaceuticals, Inc. -- SEC File Number 211148434
+ My List
ELOX Eloxx Pharmaceuticals, Inc. - Common Stock 9.82% 9.82% 0 + Biopharma, Medicine, RNA

+ My List
ENDP Endo International plc - Ordinary Shares -3.82% down 12.5% -16.32 + Medicine, Pharmaceutical , Country: Ireland, Generic


Last highlighted: Tracking Larry Robbins' Glenview Capital Management Portfolio - Q4 2020 Update
+ My List
ENLV Enlivex Therapeutics Ltd. - Ordinary Shares -7.19% down -7.01% -0.18 + Medicine

+ My List
ENOB Enochian Biosciences, Inc. - Common Stock 11.29% down 11.43% -0.14 + Disease: Infectious, Cancer fight, Immunology, Medicine

+ My List
EQ Equillium, Inc. - Common Stock 8.7% up 7.59% 1.11 + Biology, Medicine

+ My List
ESTA Establishment Labs Holdings Inc. - Common Shares 8.97% 8.97% 0 + Medicine, Implants, Women Health

+ My List
ETNB 89bio, Inc. - Common Stock up -7.19% 7.19 + Biopharma, Disease: Liver, Medicine

+ My List
ETON Eton Pharmaceuticals, Inc. - Common Stock 7.61% down 8.05% -0.44 + Medicine, Pharmaceutical

+ My List
EVGN Evogene Ltd. - Ordinary Shares 7.14% 7.14% 0 + Medicine, Biology, Artificial Intelligence


Last highlighted: #EVGN SEC report: Evogene Ltd. Report of foreign issuer [Rules 13a-16 and 15d-16]
SEC Filing Form 6-K filed by Evogene Ltd. -- SEC File Number 211161875
+ My List
EVLO Evelo Biosciences, Inc. - Common Stock 5.45% down 11.5% -6.05 + Medicine, Gene and cell

+ My List
EVOK Evoke Pharma, Inc. - Common Stock 7.27% up 4.55% 2.72 + Pharmaceutical , Medicine, Disease: Gastrointestinal


Last highlighted: FORM 8-K [Press/News Current Report] recently SEC filed. $EVOK Evoke Pharma Inc https://t.co/fwtsPe3b5z
+ My List
EYEG Eyegate Pharmaceuticals, Inc. - Common Stock -5.47% up -7.46% 1.99 + Disease: Eye , Medicine

+ My List
EYEN Eyenovia, Inc. - Common Stock -6.18% up -7.25% 1.07 + Medicine, Biopharma


Last highlighted: #EYEN SEC report: EYENOVIA, INC. [Amend] Statement of changes in beneficial ownership of securities
SEC Filing Form 4/A filed by EYENOVIA, INC. -- SEC File Number
+ My List
EYES Second Sight Medical Products, Inc. - Common Stock 6.23% down 7.32% -1.09 + Medicine, Health Devices, Disease: Eye


Last highlighted: @OliverKennett Not that I'm aware of, except for stock traders trying to manipulate pricing with reports, bullish ratings, blah, blah https://t.co/7s39zUQctu
+ My List
EYESW Second Sight Medical Products, Inc. - Warrants expiring 3/14/2024 0 + Medicine, Health Devices, Disease: Eye

+ My List
EYPT EyePoint Pharmaceuticals, Inc. - Common Stock 5.92% down 7.5% -1.58 + Pharmaceutical , Disease: Eye , Medicine, Biopharma


Last highlighted: #EYPT SEC report: EyePoint Pharmaceuticals, Inc. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by EyePoint Pharmaceuticals, Inc. -- SEC File Number 211142305
+ My List
FATE Fate Therapeutics, Inc. - Common Stock -0.44% down 7.88% -8.32 + Cancer fight, Immunology, Medicine

+ My List
FBIO Fortress Biotech, Inc. - Common Stock 6.9% down 7.59% -0.69 + Pharmaceutical , Biopharma, Biotechnology, Medicine

+ My List
FBIOP Fortress Biotech, Inc. - 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock -0.43% -0.43% 0 + Medicine, Biotechnology, Biopharma

+ My List
FBRX Forte Biosciences, Inc. - Common Stock 1.15% up -8.38% 9.53 + Skin, Medicine, Disease: Infectious, Biopharma

+ My List
FGEN FibroGen, Inc - Common Stock 6.87% down 8.15% -1.28 + Medicine, Cancer fight, Respiratory therapies / Pulmanory

+ My List
FHTX Foghorn Therapeutics Inc. - Common Stock -9.77% -9.77% 0 + Medicine, Gene and cell


Last highlighted: #FHTX SEC report: Foghorn Therapeutics Inc. Current report, items 7.01 and 9.01
SEC Filing Form 8-K filed by Foghorn Therapeutics Inc. -- SEC File Number 211089297
+ My List
FLXN Flexion Therapeutics, Inc. - Common Stock -2.22% down 7.48% -9.7 + Biopharma, Medicine, Disease: Musculoskeletal

+ My List
FOLD Amicus Therapeutics, Inc. - Common Stock -0.27% -0.27% 0 + Biopharma, Medicine


Last highlighted: #FOLD SEC report: AMICUS THERAPEUTICS, INC. Quarterly report [Sections 13 or 15(d)]
SEC Filing Form 10-Q filed by AMICUS THERAPEUTICS, INC. -- SEC File Number 211148245
+ My List
FPRX Five Prime Therapeutics, Inc. - Common Stock 0.03% 0.03% 0 + Cancer fight, Medicine

+ My List
FREQ Frequency Therapeutics, Inc. - Common Stock 2.01% 2.01% 0 + Medicine, Disease: Ear/Nose, Gene and cell


Last highlighted: $FREQ 📜 SEC Form 8-K filed by Frequency Therapeutics, Inc. https://t.co/BVOsAkh3ww #majorpharmaceuticals #healthcare
+ My List
FRLN Freeline Therapeutics Holdings plc - ADSs 2.91% down 7.67% -4.76 + Medicine, Biotechnology, Gene and cell

+ My List
FULC Fulcrum Therapeutics, Inc. - Common Stock -7.13% down -5.34% -1.79 + Medicine, Gene and cell


Last highlighted: #FULC SEC report: Fulcrum Therapeutics, Inc. Statement of acquisition of beneficial ownership by individuals
SEC Filing Form SC 13G filed by Fulcrum Therapeutics, Inc. -- SEC File Number 211160928
+ My List
FUSN Fusion Pharmaceuticals Inc. - Common Shares 9.29% 9.29% 0 + Pharmaceutical , Country: Canada, Medicine, Radiotherapy, Cancer fight

+ My List
GALT Galectin Therapeutics Inc. - Common Stock -7% up -7.25% 0.25 + Cancer fight, Disease: Liver, Skin, Medicine


Last highlighted: #GALT SEC report: GALECTIN THERAPEUTICS INC Current report, items 8.01 and 9.01
SEC Filing Form 8-K filed by GALECTIN THERAPEUTICS INC -- SEC File Number 211081679
+ My List
GBIO Generation Bio Co. - Common stock -0.53% down 8.54% -9.07 + Gene and cell, Medicine


Last highlighted: #GBIO SEC report: Generation Bio Co. Current report, items 1.01 and 9.01
SEC Filing Form 8-K filed by Generation Bio Co. -- SEC File Number 211089285
+ My List
GHSI Guardion Health Sciences, Inc. - Common Stock -8.09% -8.09% 0 + Disease: Eye , Medicine, Food, Devices


Last highlighted: #GHSI SEC report: Guardion Health Sciences, Inc. [Amend] Current report, items 2.01, 8.01, and 9.01
SEC Filing Form 8-K/A filed by Guardion Health Sciences, Inc. -- SEC File Number 211161197
+ My List
GLMD Galmed Pharmaceuticals Ltd. - Ordinary Shares 3.09% 3.09% 0 + Disease: Liver, Biopharma, Country: Israel, Medicine


Last highlighted: Galmed Pharmaceuticals Ltd current quarter revenue growth YoY of 96.40% ranked 256 out of 5424 companies in our database. https://t.co/R7UW3RpPpw $GLMD 🚀🚀🚀🚀🚀 https://t.co/HVbvEgerWf
+ My List
GLSI Greenwich LifeSciences, Inc. - Common stock 4.66% down 8.81% -4.15 + Medicine, Biopharma, Cancer fight, Immunology

+ My List
GLYC GlycoMimetics, Inc. - Common Stock 0.85% down 7.73% -6.88 + Biotechnology, Medicine, Disease: Leukemia

+ My List
GMDA Gamida Cell Ltd. - Ordinary Shares 7.86% up 7.21% 0.65 + Country: Israel, Blood, Medicine

+ My List
GNCA Genocea Biosciences, Inc. - Common Stock 8.52% 8.52% 0 + Cancer fight, Immunology, Medicine

+ My List
GNFT GENFIT S.A. - American Depositary Shares -4.95% down 15.59% -20.54 + Biopharma, Disease: Liver, Medicine

+ My List
GNPX Genprex, Inc. - Common Stock -8.48% down -7.27% -1.21 + Cancer fight, Disease: Oncology, Medicine


Last highlighted: $GNPX [15s. delayed] filed form 10-Q on August 13, 16:34:15 https://t.co/cEVufMKwcd
+ My List
GOSS Gossamer Bio, Inc. - Common Stock 14.55% down 14.89% -0.34 + Medicine

+ My List
GOVX GeoVax Labs, Inc. - Common Stock -10.19% down -9.77% -0.42 + Medicine, Cancer fight

+ My List
GRAY Graybug Vision, Inc. - Common Stock -9.07% down -8.14% -0.93 + Medicine, Disease: Eye

+ My List
GRTS Gritstone Oncology, Inc. - Common Stock -2.77% down 10.35% -13.12 + Medicine, Immunology, Cancer fight

+ My List
GTH Genetron Holdings Limited - American Depositary Shares 1.78% down 8.02% -6.24 + Cancer fight, Medicine, Disease: Oncology, Country: China


Last highlighted: $GTH / Genetron Holdings Limited ADS files form 6-K https://t.co/3DehdripqL
+ My List
HCM Hutchison China MediTech Limited - American Depositary Shares 1.96% up -0.93% 2.89 + Country: China, Medicine, Disease: Oncology, Cancer fight


Last highlighted: $HCM 📜 SEC Form 6-K filed by Hutchison China MediTech Limited https://t.co/3MQ4DYnXFz 15s delayed.
+ My List
HGEN Humanigen, Inc. - Common Stock -57.79% up -58.85% 1.06 + Biopharma, Immunology, Cancer fight, Medicine


Last highlighted: #HGEN SEC report: HUMANIGEN, INC Current report, items 7.01 and 9.01
SEC Filing Form 8-K filed by HUMANIGEN, INC -- SEC File Number 211142187
+ My List
HJLI Hancock Jaffe Laboratories, Inc. - Common Stock -0.56% down 8.51% -9.07 + Medicine, Surgery

+ My List
HOOK HOOKIPA Pharma Inc. - Common Stock -1.42% down 7.18% -8.6 + Disease: Infectious, Immunology, Cancer fight, Medicine

+ My List
HOTH Hoth Therapeutics, Inc. - Common Stock 5.43% down 8.53% -3.1 + Medicine, Biopharma, Skin

+ My List
HROW Harrow Health, Inc. - Common Stock -1.59% up -8.51% 6.92 + Medicine


Last highlighted: #HROW SEC report: HARROW HEALTH, INC. Current report, items 8.01 and 9.01
SEC Filing Form 8-K filed by HARROW HEALTH, INC. -- SEC File Number 211102815
+ My List
HRTX Heron Therapeutics, Inc. - Common Stock -7.18% -7.18% 0 + Medicine, Pharmaceutical

+ My List
HSDT Helius Medical Technologies, Inc. - Class A Common Stock 8.21% up 6.72% 1.49 + Health Devices, Medicine, Disease: Neurology/Alzheimer/Parkinson's

+ My List
HSTO Histogen Inc. - Common Stock 0 + Medicine

+ My List
HTBX Heat Biologics, Inc. - Common Stock -9.58% -9.58% 0 + Medicine, Cancer fight

+ My List
HTGM HTG Molecular Diagnostics, Inc. - Common Stock 6.03% down 7.62% -1.59 + Immunology, Medicine


Last highlighted: #HTGM SEC report: HTG MOLECULAR DIAGNOSTICS, INC Statement of changes in beneficial ownership of securities
+ My List
HUGE FSD Pharma Inc. - Class B Subordinate Voting Shares -2.38% down 8.92% -11.3 + Pharmaceutical , Medicine

+ My List
ICAD icad inc. - Common Stock 7.03% down 8.56% -1.53 + Medicine, Devices, Cancer fight


Last highlighted: #ICAD SEC report: ICAD INC Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by ICAD INC -- SEC File Number
+ My List
ICPT Intercept Pharmaceuticals, Inc. - Common Stock 2.99% down 7.26% -4.27 + Pharmaceutical , Medicine, Biopharma, Disease: Liver


Last highlighted: #ICPT SEC report: INTERCEPT PHARMACEUTICALS, INC. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by INTERCEPT PHARMACEUTICALS, INC. -- SEC File Number
+ My List
IDRA Idera Pharmaceuticals, Inc. - Common Stock 6.73% down 8.65% -1.92 + Medicine


Last highlighted: $IDRA #NASDAQ 8-K - IDERA PHARMACEUTICALS, INC. [B/A=0/0 - Bid/Ask Size=0/0 Volume=508,398 AverageVol=486,165 Outstanding=0] https://t.co/A1uGbxsr8c
+ My List
IGMS IGM Biosciences, Inc. - Common Stock -7.01% up -7.33% 0.32 + Biotechnology, Gene and cell, Medicine


Last highlighted: #IGMS SEC report: IGM Biosciences, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by IGM Biosciences, Inc. -- SEC File Number
+ My List
ILMN Illumina, Inc. - Common Stock -8.49% up -9.67% 1.18 + Medicine, Gene and cell, Biology, Cancer fight, Reproductive health


Last highlighted: #ILMN SEC report: ILLUMINA, INC. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by ILLUMINA, INC. -- SEC File Number 211148268
+ My List
IMAB I-MAB - American Depositary Shares 4.35% up 0.86% 3.49 + Country: China, Biopharma, Medicine


Last highlighted: $IMAB 📜 SEC Form 6-K filed by I-MAB https://t.co/B5768Avydp #majorpharmaceuticals #healthcare
+ My List
IMAC IMAC Holdings, Inc. - Common Stock 4.67% down 8.67% -4 + Medicine

+ My List
IMMP Immutep Limited - American Depositary Shares -5.49% up -7.55% 2.06 + Cancer fight, Medicine

+ My List
IMNM Immunome, Inc. - Common Stock 12.2% 12.2% 0 + Cancer fight, Biotechnology, Medicine, Immunology

+ My List
IMRA IMARA Inc. - Common Stock -5.05% up -7.03% 1.98 + Medicine


Last highlighted: #IMRA SEC report: IMARA Inc. Current report, items 1.01, 8.01, and 9.01
SEC Filing Form 8-K filed by IMARA Inc. -- SEC File Number 211089361
+ My List
IMRN Immuron Limited - American Depositary Shares 9.83% 9.83% 0 + Biotechnology, Country: Australia, Biopharma, Medicine


Last highlighted: $IMRN 📜 SEC Form 6-K filed by Immuron Limited https://t.co/xsrBOQcQ0a
+ My List
IMTX Immatics N.V. - Ordinary Shares 3.03% down 7.62% -4.59 + Immunology, Cancer fight, Disease: Oncology, Medicine

+ My List
IMV IMV Inc. - Common Shares 5.16% down 8.39% -3.23 + Immunology, Medicine, Country: Canada, Covid (fighting), Biopharma


Last highlighted: #IMV SEC report: IMV Inc. Report of foreign issuer [Rules 13a-16 and 15d-16]
SEC Filing Form 6-K filed by IMV Inc. -- SEC File Number 211138178
+ My List
IMVT Immunovant, Inc. - Common Stock -0.83% down 7.19% -8.02 + Medicine, Immunology


Last highlighted: #IMVT SEC report: Immunovant, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Immunovant, Inc. -- SEC File Number
+ My List
INBX Inhibrx, Inc. - Common Stock 6.43% down 11.91% -5.48 + Medicine

+ My List
INFI Infinity Pharmaceuticals, Inc. - Common Stock -0.89% down 7.21% -8.1 + Medicine, Cancer fight


Last highlighted: #INFI SEC report: INFINITY PHARMACEUTICALS, INC. Initial statement of beneficial ownership of securities
SEC Filing Form 3 filed by INFINITY PHARMACEUTICALS, INC. -- SEC File Number
+ My List
INMB INmune Bio Inc. - Common stock -8.74% up -9.26% 0.52 + Immunology, Cancer fight, Disease: Oncology, Medicine

+ My List
INO Inovio Pharmaceuticals, Inc. - Common Stock 6.12% down 8.47% -2.35 + Medicine

+ My List
INOV Inovalon Holdings, Inc. - Class A Common Stock 8.52% up 8.3% 0.22 + Medicine, Software


Last highlighted: Inovalon Announces Charitable Initiatives for 2020 https://www.inovalon.com/news/inovalon-announces-charitable-initiatives-for-2020/
+ My List
INSM Insmed, Inc. - Common Stock -0.83% down 10.04% -10.87 + Biopharma, Medicine

+ My List
IPGP IPG Photonics Corporation - Common Stock -18.28% down -18.08% -0.2 + Fiber, Laser, Manufacturing , Telecommunications , Medicine


Last highlighted: #IPGP SEC report: IPG PHOTONICS CORP Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by IPG PHOTONICS CORP -- SEC File Number 211138029
+ My List
IRIX IRIDEX Corporation - Common Stock 7% 7% 0 + Disease: Eye , Laser, Medicine, Devices


Last highlighted: #IRIX SEC report: IRIDEX CORP Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by IRIDEX CORP -- SEC File Number
+ My List
IRMD iRadimed Corporation - Common Stock -1.18% -1.18% 0 + Medicine


Last highlighted: #IRMD SEC report: IRADIMED CORP Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by IRADIMED CORP -- SEC File Number
+ My List
ISEE IVERIC bio, Inc. - Common Stock -2.75% down 7.59% -10.34 + Medicine, Biopharma


Last highlighted: #ISEE SEC report: IVERIC bio, Inc. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by IVERIC bio, Inc. -- SEC File Number 211142256
+ My List
ITOS iTeos Therapeutics, Inc. - Common Stock 2.54% 2.54% 0 + Cancer fight, Biopharma, Disease: Oncology, Immunology, Medicine


Last highlighted: $ITOS 📜 iTeos Therapeutics, Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement https://t.co/fsH6i8bthL 15s delayed.
+ My List
ITRM Iterum Therapeutics plc - Ordinary Share -40.74% up -41.67% 0.93 + Pharmaceutical , Medicine, Disease: Infectious

+ My List
JAGX Jaguar Health, Inc. - Common Stock -6.35% up -8.33% 1.98 + Medicine, Biopharma, Agritech

+ My List
JAN JanOne Inc. - Common Stock -8.47% down -6.42% -2.05 + Medicine, Pain fight

+ My List
JNCE Jounce Therapeutics, Inc. - Common Stock 13.45% up 11.9% 1.55 + Immunology, Cancer fight, Medicine

+ My List
KALA Kala Pharmaceuticals, Inc. - Common Stock 3.99% up -7.76% 11.75 + Disease: Eye , Disease: Gastrointestinal, Medicine, Biopharma

+ My List
KALV KalVista Pharmaceuticals, Inc. - Common Stock 1.41% up -7.5% 8.91 + Pharmaceutical , Medicine


Last highlighted: #KALV SEC report: KalVista Pharmaceuticals, Inc. Annual report [Section 13 and 15(d), not S-K Item 405]
SEC Filing Form 10-K filed by KalVista Pharmaceuticals, Inc. -- SEC File Number 211087997
+ My List
KDNY Chinook Therapeutics, Inc. - Common Stock -2.08% down 7.76% -9.84 + Medicine

+ My List
KIN Kindred Biosciences, Inc. - Common Stock 45.43% down 45.74% -0.31 + Animals, Biopharma, Biotechnology, Medicine, Pets


Last highlighted: #KIN SEC report: Kindred Biosciences, Inc. Definitive proxy statement relating to merger or acquisition
SEC Filing Form DEFM14A filed by Kindred Biosciences, Inc. -- SEC File Number 211102924
+ My List
KLDO Kaleido Biosciences, Inc. - Common Stock -7.06% -7.06% 0 + Medicine

+ My List
KMDA Kamada Ltd. - Ordinary Shares 6.53% down 9.97% -3.44 + Biopharma, Pharmaceutical , Medicine


Last highlighted: #KMDA SEC report: KAMADA LTD Report of foreign issuer [Rules 13a-16 and 15d-16]
SEC Filing Form 6-K filed by KAMADA LTD -- SEC File Number 211161938
+ My List
KNSA Kiniksa Pharmaceuticals, Ltd. - Class A Common Stock 0.23% up -8.75% 8.98 + Pharmaceutical , Biopharma, Medicine


Last highlighted: #KNSA SEC report: Kiniksa Pharmaceuticals, Ltd. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by Kiniksa Pharmaceuticals, Ltd. -- SEC File Number 211138062
+ My List
KOD Kodiak Sciences Inc - Common Stock 7.07% up 5.74% 1.33 + Biopharma, Disease: Eye , Medicine

+ My List
KPTI Karyopharm Therapeutics Inc. - Common Stock -7.15% -7.15% 0 + Cancer fight, Disease: Oncology, Pharmaceutical , Medicine


Last highlighted: #KPTI SEC report: Karyopharm Therapeutics Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Karyopharm Therapeutics Inc. -- SEC File Number
+ My List
KRBP Kiromic BioPharma, Inc. - Common Stock 13.1% up 8.33% 4.77 + Biopharma, Cancer fight, Immunology, Medicine


Last highlighted: #KRBP SEC report: Kiromic Biopharma, Inc. Statement of acquisition of beneficial ownership by individuals
+ My List
KRMD Repro Med Systems, Inc. - Common Stock -6.19% up -7.12% 0.93 + Medicine, Devices

+ My List
KROS Keros Therapeutics, Inc. - common stock 0.42% 0.42% 0 + Biopharma, Medicine, Hematologic and musculoskeletal disorders


Last highlighted: #KROS SEC report: Keros Therapeutics, Inc. Quarterly report [Sections 13 or 15(d)]
SEC Filing Form 10-Q filed by Keros Therapeutics, Inc. -- SEC File Number 211148197
+ My List
KRTX Karuna Therapeutics, Inc. - Common Stock -5.65% up -7.01% 1.36 + Medicine, Disease: Neurology/Alzheimer/Parkinson's


Last highlighted: #KRTX SEC report: Karuna Therapeutics, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Karuna Therapeutics, Inc. -- SEC File Number
+ My List
KTRA Kintara Therapeutics, Inc. - Common Stock 2.27% down 9.09% -6.82 + Cancer fight, Medicine

+ My List
KURA Kura Oncology, Inc. - Common Stock -4% down 9.88% -13.88 + Cancer fight, Medicine


Last highlighted: #KURA SEC report: Kura Oncology, Inc. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by Kura Oncology, Inc. -- SEC File Number 211148278
+ My List
KYMR Kymera Therapeutics, Inc. - Common Stock -7.68% -7.68% 0 + Biopharma, Medicine


Last highlighted: #KYMR SEC report: Kymera Therapeutics, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Kymera Therapeutics, Inc. -- SEC File Number
+ My List
KZR Kezar Life Sciences, Inc. - Common Stock -2.56% down 9.74% -12.3 + Immunology, Medicine

+ My List
LIFE aTyr Pharma, Inc. - Common Stock 11.42% up 10.34% 1.08 + Biology, RNA, Medicine

+ My List
LJPC La Jolla Pharmaceutical Company - Common Stock 6.45% down 7.2% -0.75 + Medicine, Biopharma


Last highlighted: #LJPC SEC report: LA JOLLA PHARMACEUTICAL CO Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by LA JOLLA PHARMACEUTICAL CO -- SEC File Number
+ My List
LLIT Lianluo Smart Limited - Class A Common Stock 32.87% 32.87% 0 + Country: China, Medicine, Manufacturing

+ My List
LNTH Lantheus Holdings, Inc. - Common Stock 7.33% 7.33% 0 + Diagnosing, Equipment, Manufacturing , Medicine


Last highlighted: $LNTH [15s. delayed] filed form 8-K on May 27, 07:06:38: Item8.01: Other Material Events https://t.co/E3mBPIdMfe
+ My List
LPTH LightPath Technologies, Inc. - Class A Common Stock 8.65% 8.65% 0 + Medicine, Manufacturing , Telecommunications

+ My List
LRMR Larimar Therapeutics, Inc. - Common Stock -8.79% -8.79% 0 + Medicine, Gene and cell, Biotechnology

+ My List
LUMO Lumos Pharma, Inc. - Common Stock 7.1% 7.1% 0 + Medicine


Last highlighted: #LUMO SEC report: LUMOS PHARMA, INC. Current report, items 7.01 and 9.01
SEC Filing Form 8-K filed by LUMOS PHARMA, INC. -- SEC File Number 211138226
+ My List
LXRX Lexicon Pharmaceuticals, Inc. - Common Stock 1.12% up -8.58% 9.7 + Medicine

+ My List
LYRA Lyra Therapeutics, Inc. - Common Stock -1.07% down 9.01% -10.08 + Medicine, Disease: Ear/Nose

+ My List
MACK Merrimack Pharmaceuticals, Inc. - Common Stock -6.7% down 8.19% -14.89 + Pharmaceutical , Cancer fight, Medicine

+ My List
MBIO Mustang Bio, Inc. - Common Stock 1.48% 1.48% 0 + Medicine, Gene and cell


Last highlighted: $MBIO 📜 SEC Form 8-K filed by Mustang Bio, Inc. https://t.co/rBa024MAHc #healthcare #majorpharmaceuticals
+ My List
MBRX Moleculin Biotech, Inc. - Common Stock 6.57% down 7.14% -0.57 + Biotechnology, Pharmaceutical , Medicine, Cancer fight, Disease: Infectious


Last highlighted: #MBRX SEC report: Moleculin Biotech, Inc. Statement of changes in beneficial ownership of securities
+ My List
MCRB Seres Therapeutics, Inc. - Common Stock 1.24% down 13.87% -12.63 + Medicine, Microbiome, Biotechnology


Last highlighted: #MCRB SEC report: Seres Therapeutics, Inc. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by Seres Therapeutics, Inc. -- SEC File Number 211137957
+ My List
MDGS Medigus Ltd. - American Depositary Shares 7.69% up 6.99% 0.7 + Medicine, Surgery, Country: Israel


Last highlighted: #MDGS SEC report: Medigus Ltd. Report of foreign issuer [Rules 13a-16 and 15d-16]
SEC Filing Form 6-K filed by Medigus Ltd. -- SEC File Number 211096985
+ My List
MDXG MiMedx Group, Inc - Common Stock 1.81% up -10.99% 12.8 + Medicine

+ My List
MEDS Trxade Group, Inc. - Common Stock 7.11% up 3.36% 3.75 + Medicine

+ My List
MESO Mesoblast Limited - American Depositary Shares -7.35% -7.35% 0 + Medicine

+ My List
MGNX MacroGenics, Inc. - Common Stock -19.24% -19.24% 0 + Medicine, Cancer fight

+ My List
MGTA Magenta Therapeutics, Inc. - Common Stock 8.16% 8.16% 0 + Gene and cell, Cancer fight, Blood, Immunology, Medicine


Last highlighted: #MGTA SEC report: Magenta Therapeutics, Inc. Notice of Effectiveness
SEC Filing Form EFFECT filed by Magenta Therapeutics, Inc. -- SEC File Number 211084159
+ My List
MGTX MeiraGTx Holdings plc - Ordinary Shares 0.8% up -9.35% 10.15 + Medicine


Last highlighted: $MGTX #NASDAQ 8-K - MeiraGTx Holdings plc [B/A=0/0 - Bid/Ask Size=0/0 Volume=203,472 AverageVol=246,411 Outstanding=0] https://t.co/LqgQp5lPmG
+ My List
MITO Stealth BioTherapeutics Corp. - American Depositary Shares 10.77% 10.77% 0 + Medicine, Biopharma, Disease: Eye

+ My List
MLND Millendo Therapeutics, Inc. - Common Stock -5.36% -5.36% 0 + Disease: Endocrine disease, Medicine

+ My List
MNKD MannKind Corporation - Common Stock -3.18% -3.18% 0 + Medicine


Last highlighted: #MNKD SEC report: MANNKIND CORP Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by MANNKIND CORP -- SEC File Number
+ My List
MNPR Monopar Therapeutics Inc. - Common Stock 0.59% up -8.06% 8.65 + Cancer fight, Medicine, Biopharma


Last highlighted: #MNPR SEC report: Monopar Therapeutics Current report, items 7.01 and 9.01
SEC Filing Form 8-K filed by Monopar Therapeutics -- SEC File Number 211138054
+ My List
MOR MorphoSys AG - American Depositary Shares 7.22% up 7.08% 0.14 + Biopharma, Medicine, Disease: Oncology, Immunology, Cancer fight

+ My List
MOTS Motus GI Holdings, Inc. - Common Stock 0 + Medicine


Last highlighted: #MOTS SEC report: Motus GI Holdings, Inc. Current report, items 1.01, 1.02, 2.03, 3.02, 7.01, and 9.01
SEC Filing Form 8-K filed by Motus GI Holdings, Inc. -- SEC File Number 211102800
+ My List
MRAM Everspin Technologies, Inc. - Common Stock 1.67% up -7.05% 8.72 + Hardware, Avia, Auto, Medicine

+ My List
MRKR Marker Therapeutics, Inc. - Common Stock 7.14% down 9.34% -2.2 + Immunology, Medicine, Cancer fight


Last highlighted: #MRKR SEC report: Marker Therapeutics, Inc. Current report, items 7.01 and 9.01
+ My List
MRSN Mersana Therapeutics, Inc. - Common Stock -9.72% -9.72% 0 + Medicine, Cancer fight


Last highlighted: #MRSN SEC report: Mersana Therapeutics, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Mersana Therapeutics, Inc. -- SEC File Number
+ My List
MRUS Merus N.V. - Common Shares -2.66% down 9.94% -12.6 + Cancer fight, Medicine, Country: Netherlands


Last highlighted: #MRUS SEC report: Merus N.V. Quarterly report [Sections 13 or 15(d)]
SEC Filing Form 10-Q filed by Merus N.V. -- SEC File Number 211148220
+ My List
MSON MISONIX, Inc. - Common Stock -0.6% down 10.98% -11.58 + Surgery, Medicine, Manufacturing

+ My List
MTCR Metacrine, Inc. - Common Stock 8.01% 8.01% 0 + Medicine

+ My List
MTEM Molecular Templates, Inc. - Common Stock 6.23% down 7.96% -1.73 + Medicine

+ My List
MTLS Materialise NV - American Depositary Shares 1.57% 1.57% 0 + 3D, Medicine, Software, Country: Belgium


Last highlighted: $MTLS 📜 SEC Form 6-K filed https://t.co/jnqtpKlQ9Y #technology
+ My List
MTP Midatech Pharma PLC - American Depositary Shares 5.75% 5.75% 0 + Country: Greate Britain, Medicine, 3D, Pharmaceutical


Last highlighted: $MTP 📜 SEC Form 6-K filed by Midatech Pharma PLC https://t.co/bXrzkJUXsF #majorpharmaceuticals #healthcare
+ My List
MYGN Myriad Genetics, Inc. - Common Stock 7.42% down 7.48% -0.06 + Gene and cell, Medicine, Women Health


Last highlighted: $MYGN SEC Filing: 8-K Earnings - MYRIAD GENETICS INC (0000899923) August 03 https://t.co/GlGu9uVj6k
+ My List
NAOV NanoVibronix, Inc. - Common Stock -3.20% -3.20% 0 + Medicine, Ultrasound


Last highlighted: $NAOV 📜 NanoVibronix, Inc. filed SEC Form 8-K: Other Events https://t.co/wbk3Kh5wgs 30s delayed.
+ My List
NARI Inari Medical, Inc. - Common Stock -8.31% -8.31% 0 + Medicine


Last highlighted: #NARI SEC report: Inari Medical, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Inari Medical, Inc. -- SEC File Number
+ My List
NBSE NeuBase Therapeutics, Inc. - Common Stock -5.01% up -8.02% 3.01 + Medicine, Gene and cell


Last highlighted: #NBSE SEC report: NeuBase Therapeutics, Inc. Notice of Effectiveness
SEC Filing Form EFFECT filed by NeuBase Therapeutics, Inc. -- SEC File Number 211078875
+ My List
NCNA NuCana plc - American Depositary Shares 7.11% up 5.86% 1.25 + Cancer fight, Disease: Oncology, Medicine

+ My List
NEOS Neos Therapeutics, Inc. - Common Stock -26.21% -26.21% 0 + Medicine, Pharmaceutical , Disease: Neurology/Alzheimer/Parkinson's

+ My List
NERV Minerva Neurosciences, Inc - Common Stock 10.78% 10.78% 0 + Medicine

+ My List
NGM NGM Biopharmaceuticals, Inc. - Common Stock -7.13% -7.13% 0 + Biopharma, Medicine


Last highlighted: $NGM 📜 NGM Biopharmaceuticals, Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits https://t.co/NbDnNxMZQc #majorpharmaceuticals #healthcare
+ My List
NH NantHealth, Inc. - Common Stock -7.62% -7.62% 0 + Cancer fight, Medicine
- Bad infrastructure
+ My List
NK NantKwest, Inc. - Common Stock 0.00% 0 + Cancer fight, Medicine, Immunology
- Bad infrastructure
+ My List
NKTX Nkarta, Inc. - Common Stock -1.09% down 7.25% -8.34 + Medicine


Last highlighted: #NKTX SEC report: Nkarta, Inc. Current report, items 1.01, 2.03, 7.01, and 9.01
SEC Filing Form 8-K filed by Nkarta, Inc. -- SEC File Number 211089268
+ My List
NLTX Neoleukin Therapeutics, Inc. - Common Stock 3.76% down 7.13% -3.37 + Medicine, Immunology


Last highlighted: #NLTX SEC report: Neoleukin Therapeutics, Inc. Current report, items 2.02, 7.01, and 9.01
SEC Filing Form 8-K filed by Neoleukin Therapeutics, Inc. -- SEC File Number 211148247
+ My List
NMRD Nemaura Medical Inc. - Common Stock -0.45% up -12.17% 11.72 + Medicine, Disease: Diabet

+ My List
NMTR 9 Meters Biopharma, Inc. - Common Stock 6.14% down 7.02% -0.88 + Biopharma, Medicine, Disease: Bowel syndrome, Disease: Celiac


Last highlighted: #NMTR SEC report: 9 METERS BIOPHARMA, INC. Current report, items 1.01, 2.01, 8.01, and 9.01
SEC Filing Form 8-K filed by 9 METERS BIOPHARMA, INC. -- SEC File Number 211096936
+ My List
NOVN Novan, Inc. - Common Stock -10.28% up -10.38% 0.1 + Medicine

+ My List
NRBO NeuroBo Pharmaceuticals, Inc. - Common Stock 7.89% 7.89% 0 + Disease: Neurology/Alzheimer/Parkinson's, Medicine


Last highlighted: #NRBO SEC report: NeuroBo Pharmaceuticals, Inc. Initial statement of beneficial ownership of securities
SEC Filing Form 3 filed by NeuroBo Pharmaceuticals, Inc. -- SEC File Number
+ My List
NTEC Intec Pharma Ltd. - Ordinary Shares -10.36% -10.36% 0 + Biopharma, Medicine, Cannabis

+ My List
NTLA Intellia Therapeutics, Inc. - Common Stock -6.26% up -7.23% 0.97 + Medicine, Gene and cell, Biotechnology, Biopharma

+ My List
NVAX Novavax, Inc. - Common Stock 0.33% up -8.52% 8.85 + Covid (fighting), Medicine, Disease: Infectious

+ My List
NVCN Neovasc Inc. - Common Shares 0 + Medicine


Last highlighted: #NVCN SEC report: NEOVASC INC Report of foreign issuer [Rules 13a-16 and 15d-16]
SEC Filing Form 6-K filed by NEOVASC INC -- SEC File Number 211181913
+ My List
NVCR NovoCure Limited - Ordinary Shares 0.31% 0.31% 0 + Cancer fight, Medicine

+ My List
NYMX Nymox Pharmaceutical Corporation - Common Stock -2.33% down 11.4% -13.73 + Medicine

+ My List
OBLN Obalon Therapeutics, Inc. - Common Stock -4% up -7.08% 3.08 + Medicine, Health Devices, Weight loss

+ My List
OCGN Ocugen, Inc. - Common Stock -5.42% up -8.37% 2.95 + Medicine, Disease: Eye


Last highlighted: #OCGN SEC report: Ocugen, Inc. Current report, items 8.01 and 9.01
+ My List
OCUP Ocuphire Pharma, Inc. - Common Stock 7.42% 7.42% 0 + Disease: Eye , Biopharma, Medicine, Pharmaceutical


Last highlighted: $OCUP 📜 Ocuphire Pharma, Inc. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits https://t.co/xMAN0ucl8b 15s delayed.
+ My List
ODT Odonate Therapeutics, Inc. - Common Stock 10% down 10.67% -0.67 + Cancer fight, Medicine


Last highlighted: #ODT SEC report: Odonate Therapeutics, Inc. Current report, items 5.02 and 9.01
SEC Filing Form 8-K filed by Odonate Therapeutics, Inc. -- SEC File Number 211148890
+ My List
OGI Organigram Holdings Inc. - Common Shares 7.17% up 6.33% 0.84 + Cannabis, Medicine, Country: Canada


Last highlighted: #OGI SEC report: ORGANIGRAM HOLDINGS INC. Report of foreign issuer [Rules 13a-16 and 15d-16]
SEC Filing Form 6-K filed by ORGANIGRAM HOLDINGS INC. -- SEC File Number 211181325
+ My List
OMER Omeros Corporation - Common Stock 0.88% down 8.34% -7.46 + Biopharma, Biotechnology, Medicine


Last highlighted: #OMER SEC report: OMEROS CORP Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by OMEROS CORP -- SEC File Number
+ My List
ONCS OncoSec Medical Incorporated - Common Stock -8.26% -8.26% 0 + Cancer fight, Disease: Oncology, Medicine, Immunology


Last highlighted: #ONCS SEC report: ONCOSEC MEDICAL Inc Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by ONCOSEC MEDICAL Inc -- SEC File Number
+ My List
ONCY Oncolytics Biotech Inc. - Common Shares -2.15% down 12.56% -14.71 + Medicine, Cancer fight, Country: Canada, Immunology


Last highlighted: $ONCY / Oncolytics Biotech files form 6-K https://t.co/G1byP6giz8
+ My List
ONEM 1Life Healthcare, Inc. - Common Stock -14.92% -14.92% 0 + Medicine, SaaS, Software, Membership


Last highlighted: A Form 10-Q [Quarterly Report] filing has been made with the SEC: $ONEM 1Life Healthcare Inc https://t.co/y307a6FL0H
+ My List
ONVO Organovo Holdings, Inc. - Common Stock 6.63% down 7.48% -0.85 + Medicine, Skin

+ My List
OPCH Option Care Health, Inc. - Common Stock down 8.22% -8.22 + Healthcare, Medicine


Last highlighted: #OPCH SEC report: Option Care Health, Inc. Current report, item 2.02
SEC Filing Form 8-K filed by Option Care Health, Inc. -- SEC File Number 211138008
+ My List
OPGN OpGen, Inc. - Common Stock 1.27% down 8.59% -7.32 + Disease: Infectious, Medicine

+ My List
OPNT Opiant Pharmaceuticals, Inc. - Common Stock 6.09% down 7.36% -1.27 + Pharmaceutical , Medicine, Alcohol, Cannabis


Last highlighted: #OPNT SEC report: OPIANT PHARMACEUTICALS, INC. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by OPIANT PHARMACEUTICALS, INC. -- SEC File Number 211148259
+ My List
OPT Opthea Limited - American Depositary Shares 8.08% up 7.26% 0.82 + Disease: Eye , Country: Canada, Medicine

+ My List
OPTN OptiNose, Inc. - Common Stock -0.37% up -7.17% 6.8 + Medicine, Disease: Ear/Nose, Pharmaceutical

+ My List
ORGS Orgenesis Inc. - Common Stock -0.2% up -7% 6.8 + Biotechnology, Medicine, Gene and cell


Last highlighted: Filing Alert, FORM 10-Q [Quarterly Report] available. $ORGS #Orgenesis Inc. Orgenesis Inc https://t.co/cwDFhLgUnk
+ My List
ORIC Oric Pharmaceuticals, Inc. - Common Stock 48.99% 48.99% 0 + Pharmaceutical , Medicine, Disease: Oncology, Cancer fight


Last highlighted: #ORIC SEC report: Oric Pharmaceuticals, Inc. Current report, items 8.01 and 9.01
SEC Filing Form 8-K filed by Oric Pharmaceuticals, Inc. -- SEC File Number 211078899
+ My List
ORMP Oramed Pharmaceuticals Inc. - Common Stock 6.12% down 7.3% -1.18 + Medicine, Pharmaceutical

+ My List
ORPH Orphazyme A/S - American Depositary Shares 8.37% up 8.16% 0.21 + Medicine, Disease: Neurology/Alzheimer/Parkinson's, Disease: Amyotrophic lateral sclerosis (ALS), Disease: Gaucher, Disease: Inclusion body myositis (IBM), Disease: Niemann-Pick type C (NPC)

+ My List
ORTX Orchard Therapeutics plc - American Depositary Shares 10.36% 10.36% 0 + Medicine, Gene and cell


Last highlighted: #ORTX SEC report: Orchard Therapeutics plc Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by Orchard Therapeutics plc -- SEC File Number 211142307
+ My List
OSUR OraSure Technologies, Inc. - Common Stock 11.98% 11.98% 0 + Medicine, Diagnosing

+ My List
OTLK Outlook Therapeutics, Inc. - Common Stock 7.22% 7.22% 0 + Disease: Eye , Biopharma, Medicine


Last highlighted: #OTLK SEC report: Outlook Therapeutics, Inc. Initial statement of beneficial ownership of securities
SEC Filing Form 3 filed by Outlook Therapeutics, Inc. -- SEC File Number
+ My List
OVID Ovid Therapeutics Inc. - Common Stock -0.29% -0.29% 0 + Medicine

+ My List
PAND Pandion Therapeutics Inc. - Common stock 0.17% 0.17% 0 + Immunology, Medicine, Organ transplants


Last highlighted: SEC Form 8-K [Press/News Current Report] filed by $PAND #PandionTherapeutics, Inc https://t.co/uNtZ9rhD94
+ My List
PASG Passage Bio, Inc. - Common Stock -2.7% down 7.38% -10.08 + Gene and cell, Medicine


Last highlighted: #PASG SEC report: Passage BIO, Inc. Current report, item 5.02
SEC Filing Form 8-K filed by Passage BIO, Inc. -- SEC File Number 211102754
+ My List
PAVM PAVmed Inc. - Common Stock down 9.45% -9.45 + Medicine, Devices


Last highlighted: #PAVM SEC report: PAVmed Inc. Current report, items 7.01 and 9.01
SEC Filing Form 8-K filed by PAVmed Inc. -- SEC File Number 211138283
+ My List
PCVX Vaxcyte, Inc. - Common Stock 16.37% 16.37% 0 + Medicine

+ My List
PDSB PDS Biotechnology Corporation - Common Stock 4.86% down 7.35% -2.49 + Biotechnology, Immunology, Cancer fight, Disease: Oncology, Medicine


Last highlighted: RT @EdgarInsider: FORM 8-K [Press/News Current Report] recently SEC filed. $PDSB $EDGE PDS Biotechnology Corp https://t.co/FKxSQ3btJT
+ My List
PETS PetMed Express, Inc. - Common Stock 11.81% 11.81% 0 + Animals, Medicine, Pets

+ My List
PGEN Precigen, Inc. - Common Stock 9.55% 9.55% 0 + Biopharma, Gene and cell, Medicine


Last highlighted: #PGEN SEC report: PRECIGEN, INC. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by PRECIGEN, INC. -- SEC File Number
+ My List
PGNY Progyny, Inc. - Common Stock 7.7% down 8.25% -0.55 + Medicine

+ My List
PHAS PhaseBio Pharmaceuticals, Inc. - Common Stock -1.37% down 7.83% -9.2 + Medicine

+ My List
PHIO Phio Pharmaceuticals Corp. - Common Stock 8.49% up 2.83% 5.66 + Medicine, Cancer fight, Immunology


Last highlighted: #PHIO SEC report: Phio Pharmaceuticals Corp. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Phio Pharmaceuticals Corp. -- SEC File Number
+ My List
PIRS Pieris Pharmaceuticals, Inc. - Common Stock -4.22% down 11.62% -15.84 + Biopharma, Respiratory therapies / Pulmanory, Medicine, Immunology, Cancer fight


Last highlighted: #PIRS SEC report: PIERIS PHARMACEUTICALS, INC. Current report, items 2.02, 7.01, and 9.01
SEC Filing Form 8-K filed by PIERIS PHARMACEUTICALS, INC. -- SEC File Number 211142334
+ My List
PLRX Pliant Therapeutics, Inc. - Common Stock -13.49% -13.49% 0 + Biopharma, Medicine

+ My List
PLSE Pulse Biosciences, Inc - Common Stock -8.6% -8.6% 0 + Medicine

+ My List
PLXP PLx Pharma Inc. - Common Stock 8.58% up 8.41% 0.17 + Disease: Gastrointestinal, Medicine, Pharmaceutical

+ My List
PMD Psychemedics Corporation - Common Stock 9.98% down 10.62% -0.64 + Medicine, Hair

+ My List
PMVP PMV Pharmaceuticals, Inc. - Common Stock 0.32% up -7.71% 8.03 + Medicine, Cancer fight, Pharmaceutical


Last highlighted: #PMVP SEC report: PMV Pharmaceuticals, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by PMV Pharmaceuticals, Inc. -- SEC File Number
+ My List
POAI Predictive Oncology Inc. - Common Stock 5.77% down 8.65% -2.88 + Cancer fight, Medicine, Artificial Intelligence


Last highlighted: #POAI SEC report: Predictive Oncology Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Predictive Oncology Inc. -- SEC File Number
+ My List
PRAX Praxis Precision Medicines, Inc. - Common Stock -1.43% up -7.95% 6.52 + Biopharma, Gene and cell, Disease: Central nervous system (CNS), Medicine


Last highlighted: Research Analysts Set Expectations for Praxis Precision Medicines, Inc.’s Q1 2022 Earnings $PRAX https://t.co/u6zv6m9Tyz #markets
+ My List
PRFX PainReform Ltd. - Ordinary Shares 9.06% up 3.83% 5.23 + Medicine, Surgery

+ My List
PRLD Prelude Therapeutics Incorporated - Common Stock up -8.01% 8.01 + Cancer fight, Medicine


Last highlighted: #PRLD SEC report: Prelude Therapeutics Inc Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Prelude Therapeutics Inc -- SEC File Number
+ My List
PROG Progenity, Inc. - Common Stock -2.91% up -10.81% 7.9 + Gene and cell, Medicine, Cancer fight, Women Health


Last highlighted: #PROG SEC report: PROGENITY, INC. Initial statement of beneficial ownership of securities
SEC Filing Form 3 filed by PROGENITY, INC. -- SEC File Number
+ My List
PRPH ProPhase Labs, Inc. - Common Stock -1.18% up -11.36% 10.18 + Medicine, Healthcare


Last highlighted: $PRPH / ProPhase Labs files form 10-K https://t.co/Q6uC0NSvV4
+ My List
PRPO Precipio, Inc. - Common Stock -5.95% up -8.04% 2.09 + Medicine

+ My List
PRQR ProQR Therapeutics N.V. - Ordinary Shares 0.77% up -7.62% 8.39 + Medicine, Biotechnology, Disease: Eye , RNA

+ My List
PRTA Prothena Corporation plc - Ordinary Shares -9.39% -9.39% 0 + Country: Ireland, Disease: Neurology/Alzheimer/Parkinson's, Medicine

+ My List
PRTK Paratek Pharmaceuticals, Inc. - Common Stock 10.1% 10.1% 0 + Pharmaceutical , Biopharma, Medicine, Life Sciences

+ My List
PRVB Provention Bio, Inc. - Common Stock 1.61% up -7.44% 9.05 + Immunology, Medicine


Last highlighted: #PRVB SEC report: Provention Bio, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Provention Bio, Inc. -- SEC File Number
+ My List
PSTV PLUS THERAPEUTICS, Inc. - Common Stock -1.52% up -11.61% 10.09 + Cancer fight, Medicine, Radiotherapy


Last highlighted: #PSTV SEC report: PLUS THERAPEUTICS, INC. [Amend] Quarterly report [Sections 13 or 15(d)]
+ My List
PSTX Poseida Therapeutics, Inc. - Common Stock -2.66% up -19.19% 16.53 + Medicine, Gene and cell


Last highlighted: #PSTX SEC report: Poseida Therapeutics, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Poseida Therapeutics, Inc. -- SEC File Number
+ My List
PTGX Protagonist Therapeutics, Inc. - Common Stock -9.56% down -9.42% -0.14 + Medicine

+ My List
QDEL Quidel Corporation - Common Stock -1.71% -1.71% 0 + Medicine, Disease: Infectious, Immunology


Last highlighted: $QDEL 8-K Quidel (22 Apr, 4:53pm) 📰 Quidel Announces Preliminary Revenue for First Quarter 2021 https://t.co/LsfiDmSNca #QDEL #8K #Quidel #News
+ My List
QTNT Quotient Limited - Ordinary Shares 3.27% 3.27% 0 + Country: Switzerland, Medicine, Diagnosing


Last highlighted: $QTNT 8-K Quotient (2 Jul, 4:10pm) 📰 Quotient Limited Announces Departure of Chief Financial Officer, Peter Buhler https://t.co/xRYRhCFTbh #QTNT #8K #Quotient #News
+ My List
RACA Therapeutics Acquisition Corp. - Class A Common Stock 7% 7% 0 + Acquisitions/Investing, Medicine, Health Devices

+ My List
RAPT RAPT Therapeutics, Inc. - Common Stock 6.99% down 7.08% -0.09 + Cancer fight, Medicine


Last highlighted: #RAPT SEC report: RAPT Therapeutics, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by RAPT Therapeutics, Inc. -- SEC File Number
+ My List
RCEL Avita Therapeutics, Inc. - Common Stock 10.86% up 10.8% 0.059999999999999 + Regenerative, Medicine

+ My List
RDUS Radius Health, Inc. - Common Stock 0.41% 0.41% 0 + Medicine


Last highlighted: $RDUS Radius Health, Inc. Provides Business Update https://t.co/j4BQxHhJD0
+ My List
REPH Recro Pharma, Inc. - Common Stock -1.95% down 7.56% -9.51 + Medicine

+ My List
RETA Reata Pharmaceuticals, Inc. - Class A Common Stock -0.04% up -7.19% 7.15 + Pharmaceutical , Disease: Kidney, Medicine

+ My List
RGLS Regulus Therapeutics Inc. - Common Stock 0 + RNA, Biopharma, Medicine

+ My List
RGNX REGENXBIO Inc. - Common Stock 2.88% down 9.63% -6.75 + Gene and cell, Biotechnology, Medicine

+ My List
RIGL Rigel Pharmaceuticals, Inc. - Common Stock 1.47% down 8.36% -6.89 + Medicine, Cancer fight

+ My List
RLMD Relmada Therapeutics, Inc. - Common Stock 1.08% 1.08% 0 + Disease: Central nervous system (CNS), Biotechnology, Medicine


Last highlighted: $RLMD 📜 SEC Form 10-Q filed by Relmada Therapeutics, Inc. https://t.co/CGB5BcamVJ 30s delayed. This insight appeared in real-time at 🚆 https://t.co/TvhaBDQJ0C 🚆
+ My List
RNA Avidity Biosciences, Inc. - Common Stock -6.02% up -7.44% 1.42 + Medicine, Gene and cell


Last highlighted: #RNA SEC report: Avidity Biosciences, Inc. Prospectus [Rule 424(b)(5)]
SEC Filing Form 424B5 filed by Avidity Biosciences, Inc. -- SEC File Number 211136619
+ My List
RNLX Renalytix AI plc - American Depositary Shares 3.76% 3.76% 0 + Country: Greate Britain, Medicine, Disease: Kidney, Artificial Intelligence


Last highlighted: $RNLX 6-K Renalytix AI (2 Mar, 6:10am) 📰 RenalytixAI Reports Financial Results for Second Quarter of Fiscal Year 2021 https://t.co/XIBCrGVTeh #RNLX #6K #RenalytixAI #News
+ My List
RUBY Rubius Therapeutics, Inc. - Common Stock down 7.85% -7.85 + Gene and cell, Cancer fight, Medicine

+ My List
RVMD Revolution Medicines, Inc. - Common Stock 3.5% up -8.48% 11.98 + Cancer fight, Medicine, Biotechnology

+ My List
RYTM Rhythm Pharmaceuticals, Inc. - Common Stock 1.7% down 8.03% -6.33 + Pharmaceutical , Gene and cell, Medicine


Last highlighted: #RYTM SEC report: RHYTHM PHARMACEUTICALS, INC. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by RHYTHM PHARMACEUTICALS, INC. -- SEC File Number 211137945
+ My List
RZLT Rezolute, Inc. - Common Stock -7.64% -7.64% 0 + Biopharma, Medicine, Disease: Hypoglycemia


Last highlighted: #RZLT SEC report: Rezolute, Inc. Current report, items 7.01 and 9.01
SEC Filing Form 8-K filed by Rezolute, Inc. -- SEC File Number 211161853
+ My List
SAVA Cassava Sciences, Inc. - Common Stock -4.1% down 10.16% -14.26 + Disease: Neurology/Alzheimer/Parkinson's, Medicine, Biopharma

+ My List
SBBP Strongbridge Biopharma plc - Ordinary Shares -0.46% down 18.72% -19.18 + Disease: Neurology/Alzheimer/Parkinson's, Medicine


Last highlighted: #SBBP SEC report: Strongbridge Biopharma plc Statement of acquisition of beneficial ownership by individuals
SEC Filing Form SC 13G filed by Strongbridge Biopharma plc -- SEC File Number 211083456
+ My List
SCPH scPharmaceuticals Inc. - Common Stock -1.46% down 8.78% -10.24 + Pharmaceutical , Medicine


Last highlighted: $SCPH [15s. delayed] filed form 8-K on July 01, 08:10:00: Item8.01: Other Material Events https://t.co/XvnQaKOhSx
+ My List
SCYX SCYNEXIS, Inc. - Common Stock -0.96% up -7.43% 6.47 + Medicine

+ My List
SDC SmileDirectClub, Inc. - Common Stock 14.92% down 16.16% -1.24 + Medicine, Smile, Teeth


Last highlighted: $SDC / SmileDirectClub, Inc. files form 8-K - Other Events - 8-K https://t.co/mamr86yEBe
+ My List
SEEL Seelos Therapeutics, Inc. - Common Stock 6.32% down 8.42% -2.1 + Disease: Neurology/Alzheimer/Parkinson's, Medicine

+ My List
SELB Selecta Biosciences, Inc. - Common Stock 6.48% down 7.73% -1.25 + Biotechnology, Immunology, Biology, Medicine


Last highlighted: $SELB Selecta Biosciences, Inc. SEC Filing: Form 8-K https://t.co/0XklTmmzMS
+ My List
SESN Sesen Bio, Inc. - Common Stock 5% down 7% -2 + Cancer fight, Medicine


Last highlighted: #SESN SEC report: Sesen Bio, Inc. Current report, items 5.02 and 9.01
SEC Filing Form 8-K filed by Sesen Bio, Inc. -- SEC File Number 211102791
+ My List
SIBN SI-BONE, Inc. - Common Stock 8.67% 8.67% 0 + Medicine

+ My List
SLDB Solid Biosciences Inc. - Common Stock 6.94% down 7.35% -0.41 + Medicine

+ My List
SLNO Soleno Therapeutics, Inc. - Common Stock 0 + Medicine


Last highlighted: $SLNO 📜 Soleno Therapeutics, Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits https://t.co/U0DpuUGHhD #healthcare
+ My List
SLRX Salarius Pharmaceuticals, Inc. - Common Stock -0.97% -0.97% 0 + Cancer fight, Biotechnology, Medicine, Pharmaceutical


Last highlighted: $SLRX 8-K Salarius Pharmaceuticals (8 Mar, 4:30pm) 📰 Salarius Announces Pricing of $20 Million Underwritten Public Offering of Common Stock https://t.co/AWdEx2wgvD #SLRX #8K #SalariusPharmaceuticals #News
+ My List
SLS SELLAS Life Sciences Group, Inc. - Common Stock 9.26% up 5.36% 3.9 + Cancer fight, Medicine


Last highlighted: SELLAS Announces Positive Follow-up Data from the Randomized Phase 2 VADIS Trial of Nelipepimut-S (NPS) in Women with Ductal Carcinoma In-Situ of the Breast https://www.sellaslifesciences.com/investors/news/News-Details/2020/SELLAS-Announces-Positive-Follow-up-Data-from-the-Randomized-Phase-2-VADIS-Trial-of-Nelipepimut-S-NPS-in-Women-with-Ductal-Carcinoma-In-Situ-of-the-Breast/default.aspx
+ My List
SMMT Summit Therapeutics Inc. - Common Stock -1.04% up -8.15% 7.11 + Medicine


Last highlighted: #SMMT SEC report: Summit Therapeutics Inc. Current report, item 5.02
SEC Filing Form 8-K filed by Summit Therapeutics Inc. -- SEC File Number 211083234
+ My List
SNGX Soligenix, Inc. - Common Stock -6.14% up -7.02% 0.88 + Medicine


Last highlighted: $SNGX #NASDAQ 8-K - SOLIGENIX, INC. [B/A=0/0 - Bid/Ask Size=0/0 Volume=601,549 AverageVol=659,464 Outstanding=0] https://t.co/G9pVhHFqYY
+ My List
SNOA Sonoma Pharmaceuticals, Inc. - Common Stock 1.27% down 7.05% -5.78 + Medicine


Last highlighted: #SNOA SEC report: Sonoma Pharmaceuticals, Inc. Current report, items 4.01 and 9.01
SEC Filing Form 8-K filed by Sonoma Pharmaceuticals, Inc. -- SEC File Number 211083166
+ My List
SNSS Sunesis Pharmaceuticals, Inc. - Common Stock 0.00% 0 + Medicine, Biopharma, Cancer fight

+ My List
SONN Sonnet BioTherapeutics Holdings, Inc. - Common Stock -45.05% down -44.14% -0.91 + Cancer fight, Biology, Medicine

+ My List
SPNE SeaSpine Holdings Corporation - Common Stock 6.71% down 8.68% -1.97 + Acquisitions/Investing, Medicine, Implants, Surgery, Disease: Spinal


Last highlighted: #SPNE SEC report: SeaSpine Holdings Corp Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by SeaSpine Holdings Corp -- SEC File Number
+ My List
SPRO Spero Therapeutics, Inc. - Common Stock 6.29% down 7.78% -1.49 + Disease: Infectious, Biopharma, Medicine

+ My List
SRGA Surgalign Holdings, Inc. - Common Stock -6.83% up -9.94% 3.11 + Pain fight, Medicine, Health Devices, Spine


Last highlighted: #SRGA SEC report: SURGALIGN HOLDINGS, INC. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by SURGALIGN HOLDINGS, INC. -- SEC File Number
+ My List
SRNE Sorrento Therapeutics, Inc. - Common Stock 6.56% down 8% -1.44 + Pain fight, Cancer fight, Medicine

+ My List
SRRK Scholar Rock Holding Corporation - Common Stock 6.28% down 7.74% -1.46 + Medicine, Disease: Spinal, Disease: Oncology, Fibrosis


Last highlighted: #SRRK SEC report: Scholar Rock Holding Corp Current report, items 5.02, 7.01, and 9.01
SEC Filing Form 8-K filed by Scholar Rock Holding Corp -- SEC File Number 211137996
+ My List
SRTS Sensus Healthcare, Inc. - Common Stock -7.1% -7.1% 0 + Skin, Medicine


Last highlighted: #SRTS SEC report: Sensus Healthcare, Inc. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by Sensus Healthcare, Inc. -- SEC File Number 211148448
+ My List
STIM Neuronetics, Inc. - Common Stock 7.51% up 7.08% 0.43 + Disease: Neurology/Alzheimer/Parkinson's, Medicine


Last highlighted: #STIM SEC report: Neuronetics, Inc. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by Neuronetics, Inc. -- SEC File Number 211137986
+ My List
STRO Sutro Biopharma, Inc. - Common Stock -0.1% down 8.09% -8.19 + Cancer fight, Medicine

+ My List
SURF Surface Oncology, Inc. - Common Stock 13.37% 13.37% 0 + Cancer fight, Immunology, Medicine


Last highlighted: #SURF SEC report: Surface Oncology, Inc. Current report, items 5.02 and 9.01
SEC Filing Form 8-K filed by Surface Oncology, Inc. -- SEC File Number 211078938
+ My List
SVRA Savara, Inc. - Common Stock -0.77% up -7.97% 7.2 + Respiratory therapies / Pulmanory, Medicine

+ My List
SWAV ShockWave Medical, Inc. - Common Stock 6.26% down 7.56% -1.3 + Medicine, Devices


Last highlighted: #SWAV SEC report: Shockwave Medical, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Shockwave Medical, Inc. -- SEC File Number
+ My List
SY So-Young International Inc. - American Depository Shares 5.66% down 7.69% -2.03 + Country: China, Medicine, Healthcare, Community

+ My List
SYBX Synlogic, Inc. - Common Stock 7.09% up 6.38% 0.71 + Biology, Medicine

+ My List
SYRS Syros Pharmaceuticals, Inc. - common stock -5.03% up -10.06% 5.03 + Gene and cell, Medicine, Cancer fight

+ My List
TARA Protara Therapeutics, Inc. - Common Stock -5.98% up -7.2% 1.22 + Cancer fight, Medicine

+ My List
TARS Tarsus Pharmaceuticals, Inc. - Common Stock 0.49% up -7.7% 8.19 + Medicine, Disease: Eye

+ My List
TBIO Translate Bio, Inc. - Common Stock 1.36% 1.36% 0 + Medicine


Last highlighted: #TBIO SEC report: Translate Bio, Inc. Current report, items 1.01, 8.01, and 9.01
SEC Filing Form 8-K filed by Translate Bio, Inc. -- SEC File Number 211138046
+ My List
TCON TRACON Pharmaceuticals, Inc. - Common Stock 3.28% down 11.48% -8.2 + Pharmaceutical , Cancer fight, Medicine, Biopharma, Disease: Oncology

+ My List
TCRR TCR2 Therapeutics Inc. - Common Stock 1.38% up -10.44% 11.82 + Cancer fight, Medicine

+ My List
TELA TELA Bio, Inc. - Common stock 0.00% 0 + Medicine, Surgery


Last highlighted: A new filing Form 8-K [Press/News Current Report] has been made at the SEC by $TELA TELA Bio, Inc. TELA Bio, Inc https://t.co/7dnHH48pr5
+ My List
TENX Tenax Therapeutics, Inc. - Common Stock -6.71% up -7.38% 0.67 + Pharmaceutical , Medicine


Last highlighted: #TENX SEC report: TENAX THERAPEUTICS, INC. [Amend] General statement of acquisition of beneficial ownership
SEC Filing Form SC 13D/A filed by TENAX THERAPEUTICS, INC. -- SEC File Number 211083528
+ My List
THTX Theratechnologies Inc. - Common Shares -6.65% down 8.31% -14.96 + Cancer fight, Biopharma, Medicine

+ My List
TLC Taiwan Liposome Company, Ltd. - American Depositary Shares 14.83% 14.83% 0 + Country: Taiwan, Medicine, Pain fight, Disease: Oncology, Disease: Infectious, Ophthalmology


Last highlighted: #TLC SEC report: Taiwan Liposome Company, Ltd. Appointment of Agent for Service of Process and Undertaking
SEC Filing Form F-X filed by Taiwan Liposome Company, Ltd. -- SEC File Number 211147635
+ My List
TLMD SOC Telemed, Inc. - Class A Common Stock up -7.42% 7.42 + Medicine, Telemedicine, Disease: Neurology/Alzheimer/Parkinson's, Disease: Infectious, Disease: Cardiology


Last highlighted: #TLMD SEC report: SOC Telemed, Inc. Notice of Effectiveness
SEC Filing Form EFFECT filed by SOC Telemed, Inc. -- SEC File Number 211161810
+ My List
TLMDW SOC Telemed, Inc. - Warrants 0 + Acquisitions/Investing, Medicine

+ My List
TLRY Tilray, Inc. - Class 2 Common Stock -3.33% down 7.8% -11.13 + Biopharma, Cannabis, Medicine, Country: Canada, Reddit's Wave


Last highlighted: #TLRY SEC report: Tilray, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Tilray, Inc. -- SEC File Number
+ My List
TMDX TransMedics Group, Inc. - Common Stock -2.3% up -8.93% 6.63 + Medicine, Transplant


Last highlighted: #TMDX SEC report: TransMedics Group, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by TransMedics Group, Inc. -- SEC File Number
+ My List
TNXP Tonix Pharmaceuticals Holding Corp. - Common Stock up -35.29% 35.29 + Medicine, Biopharma, Immunology, Disease: Addictions, Disease: Neurology/Alzheimer/Parkinson's, Disease: Central nervous system (CNS)


Last highlighted: $TNXP TONIX PHARMACEUTICALS HOLDING CORP. (NASDAQ:TNXP) Files An 8-K Regulation FD Disclosure https://t.co/hFCRf3OmpX
+ My List
TOMZ TOMI Environmental Solutions, Inc. - Common Stock 13.21% up 12.74% 0.47 + Disease: Infectious, Medicine, Equipment, Life Sciences, Food, Covid (fighting)


Last highlighted: #TOMZ SEC report: TOMI Environmental Solutions, Inc. Current report, item 5.02
SEC Filing Form 8-K filed by TOMI Environmental Solutions, Inc. -- SEC File Number 211138196
+ My List
TRHC Tabula Rasa HealthCare, Inc. - Common Stock -5.66% up -8.62% 2.96 + Healthcare, Medicine


Last highlighted: Tabula Rasa HealthCare, Inc. 2021 Q1 - Results - Earnings Call Presentation
+ My List
TRVN Trevena, Inc. - Common Stock 6.56% down 8.2% -1.64 + Biopharma, Medicine, Disease: Central nervous system (CNS)


Last highlighted: $TRVN Trading is easy with Buy and Short signals displayed on the chart https://t.co/optkvg9qmr
+ My List
TSHA Taysha Gene Therapies, Inc. - Common Stock -8.83% down -8.11% -0.72 + Gene and cell, Disease: Central nervous system (CNS), Medicine

+ My List
TTMI TTM Technologies, Inc. - Common Stock -0.88% -0.88% 0 + Manufacturing , Medicine, Auto, Avia, Hardware, Network Infrastructure

+ My List
TTNP Titan Pharmaceuticals, Inc. - Common Stock 5.63% down 7.98% -2.35 + Biopharma, Disease: Central nervous system (CNS), Medicine

+ My List
TTOO T2 Biosystems, Inc. - Common Stock -5.88% up -7.84% 1.96 + Medicine, Cancer fight


Last highlighted: #TTOO SEC report: T2 Biosystems, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by T2 Biosystems, Inc. -- SEC File Number
+ My List
TWST Twist Bioscience Corporation - Common Stock 6.76% down 7.6% -0.84 + Biotechnology, RNA, Medicine


Last highlighted: #TWST SEC report: Twist Bioscience Corp Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Twist Bioscience Corp -- SEC File Number
+ My List
TXMD TherapeuticsMD, Inc. - Common Stock up -8% 8 + Women Health, Pharmaceutical , Medicine
- Bad infrastructure

Last highlighted: #TXMD SEC report: TherapeuticsMD, Inc. Current report, items 2.02, 7.01, and 9.01
SEC Filing Form 8-K filed by TherapeuticsMD, Inc. -- SEC File Number 211142293
+ My List
TYHT Shineco, Inc. - Common Stock 10.78% 10.78% 0 + Agritech, Medicine


Last highlighted: #TYHT SEC report: SHINECO, INC. Current report, items 1.01, 2.03, and 9.01
SEC Filing Form 8-K filed by SHINECO, INC. -- SEC File Number 211102851
+ My List
TYME Tyme Technologies, Inc. - Common Stock 4.9% down 7.84% -2.94 + Cancer fight, Medicine


Last highlighted: #TYME SEC report: TYME TECHNOLOGIES, INC. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by TYME TECHNOLOGIES, INC. -- SEC File Number
+ My List
VBLT Vascular Biogenics Ltd. - Ordinary Shares -2.55% down 7.8% -10.35 + Country: Israel, Biopharma, Cancer fight, Medicine

+ My List
VCEL Vericel Corporation - Common Stock -2.84% -2.84% 0 + Biopharma, Medicine, Sport

+ My List
VCNX Vaccinex, Inc. - Common Stock 5.5% down 7.34% -1.84 + Disease: Neurology/Alzheimer/Parkinson's, Medicine

+ My List
VCYT Veracyte, Inc. - Common Stock 9.58% 9.58% 0 + Healthcare, Medicine


Last highlighted: #VCYT SEC report: VERACYTE, INC. Current report, items 2.01 and 3.02
SEC Filing Form 8-K filed by VERACYTE, INC. -- SEC File Number 211138060
+ My List
VERO Venus Concept Inc. - Common Stock 5.8% down 7.14% -1.34 + Medicine, Devices, Beauty, Skin


Last highlighted: #VERO SEC report: Venus Concept Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Venus Concept Inc. -- SEC File Number
+ My List
VERU Veru Inc. - Common Stock -1.52% down 9.99% -11.51 + Cancer fight, Medicine


Last highlighted: Veru, Inc. (VERU) CEO Mitchell Steiner on Q4 2020 Results - Earnings Call Transcript
+ My List
VIR Vir Biotechnology, Inc. - Common Stock -6.84% up -7.18% 0.34 + Immunology, Medicine


Last highlighted: #VIR SEC report: Vir Biotechnology, Inc. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by Vir Biotechnology, Inc. -- SEC File Number 211148349
+ My List
VIVO Meridian Bioscience Inc. - Common Stock 0.77% 0.77% 0 + Medicine, Diagnosing, Healthcare

+ My List
VMD Viemed Healthcare, Inc. - Common Shares 1.57% down 7.48% -5.91 + Respiratory therapies / Pulmanory, Medicine, Equipment, Home


Last highlighted: #VMD SEC report: VIEMED HEALTHCARE, INC. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by VIEMED HEALTHCARE, INC. -- SEC File Number 211136963
+ My List
VRAY ViewRay, Inc. - Common Stock 3.38% down 9.2% -5.82 + Cancer fight, Radiotherapy, Medicine


Last highlighted: #VRAY SEC report: ViewRay, Inc. Current report, items 2.02, 7.01, and 9.01
SEC Filing Form 8-K filed by ViewRay, Inc. -- SEC File Number 211148242
+ My List
VRNA Verona Pharma plc - American Depositary Shares 4.46% down 7.2% -2.74 + Respiratory therapies / Pulmanory, Country: Greate Britain, Medicine


Last highlighted: #VRNA SEC report: Verona Pharma plc Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Verona Pharma plc -- SEC File Number
+ My List
VSPRU Vesper Healthcare Acquisition Corp. - Unit 4.74% down 7.44% -2.7 + Acquisitions/Investing, Healthcare, Medicine, Pharmaceutical


Last highlighted: $VSPRU [15s. delayed] filed form 8-K/A on April 27, 08:49:59: Item8.01: Other Material Events https://t.co/lO6rnv4ril
+ My List
VSTM Verastem, Inc. - Common Stock 6.02% down 8.43% -2.41 + Biopharma, Cancer fight, Medicine


Last highlighted: #VSTM SEC report: Verastem, Inc. Automatic shelf registration statement of securities of well-known seasoned issuers
SEC Filing Form S-3ASR filed by Verastem, Inc. -- SEC File Number 211136620
+ My List
VTGN VistaGen Therapeutics, Inc. - Common Stock -6.15% up -7.12% 0.97 + Medicine, Smile


Last highlighted: #VTGN SEC report: VistaGen Therapeutics, Inc. Initial statement of beneficial ownership of securities
SEC Filing Form 3 filed by VistaGen Therapeutics, Inc. -- SEC File Number
+ My List
VTVT vTv Therapeutics Inc. - Class A Common Stock 3.55% down 7.69% -4.14 + Medicine

+ My List
VXRT Vaxart, Inc. - Common Stock 5.33% down 9.36% -4.03 + Covid (fighting), Medicine


Last highlighted: #VXRT SEC report: Vaxart, Inc. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by Vaxart, Inc. -- SEC File Number 211148203
+ My List
VYGR Voyager Therapeutics, Inc. - Common Stock -7.38% -7.38% 0 + Disease: Neurology/Alzheimer/Parkinson's, Medicine, Healthcare

+ My List
WINT Windtree Therapeutics, Inc. - Common Stock 1.08% down 9.34% -8.26 + Biopharma, Respiratory therapies / Pulmanory, Medicine

+ My List
WORX SCWorx Corp. - Common Stock 0.88% up -8.98% 9.86 + Medicine, Logistics

+ My List
WVE Wave Life Sciences Ltd. - Ordinary Shares 2.55% up -10.59% 13.14 + Medicine, Biotechnology, Life Sciences

+ My List
XAIR Beyond Air, Inc. - Common Stock 7.58% up 7.5% 0.08 + Respiratory therapies / Pulmanory, Medicine, Biopharma

+ My List
XBIO Xenetic Biosciences, Inc. - Common Stock -6.77% up -7.42% 0.65 + Biopharma, Cancer fight, Disease: Oncology, Medicine

+ My List
XCUR Exicure, Inc. - Common Stock 1.47% 1.47% 0 + Gene and cell, Medicine


Last highlighted: $XCUR 8-K Exicure (12 May, 4:13pm) 📰 Exicure, Inc. Reports First Quarter 2021 Financial Results and Corporate Progress https://t.co/VEYCSavonT #XCUR #8K #Exicure #News
+ My List
XFOR X4 Pharmaceuticals, Inc. - Common Stock 4.55% up -8.7% 13.25 + Cancer fight, Medicine, Pharmaceutical


Last highlighted: #XFOR SEC report: X4 Pharmaceuticals, Inc Current report, item 2.02
SEC Filing Form 8-K filed by X4 Pharmaceuticals, Inc -- SEC File Number 211138073
+ My List
XOMA XOMA Corporation - Common Stock -12.53% up -12.57% 0.040000000000001 + Biotechnology, Medicine, Acquisitions/Investing

+ My List
YMAB Y-mAbs Therapeutics, Inc. - Common Stock 0.03% down 7.31% -7.28 + Biopharma, Cancer fight, Medicine


Last highlighted: #YMAB SEC report: Y-mAbs Therapeutics, Inc. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by Y-mAbs Therapeutics, Inc. -- SEC File Number 211148421
+ My List
ZIOP ZIOPHARM Oncology Inc - Common Stock -1.79% up -10.44% 8.65 + T cell-based, Cancer fight, Disease: Oncology, Immunology, Medicine

+ My List
ZNTL Zentalis Pharmaceuticals, Inc. - common stock 9.19% 9.19% 0 + Cancer fight, Biology, Pharmaceutical , Medicine


Last highlighted: #ZNTL SEC report: Zentalis Pharmaceuticals, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Zentalis Pharmaceuticals, Inc. -- SEC File Number
+ My List
ZSAN Zosano Pharma Corporation - Common Stock 0 + Biopharma, Medicine

+ My List
ZYNE Zynerba Pharmaceuticals, Inc. - Common Stock -0.91% down 8.96% -9.87 + Cannabis, Medicine, Pharmaceutical , Disease: Neuropsychiatric


Last highlighted: #ZYNE SEC report: Zynerba Pharmaceuticals, Inc. Current report, items 8.01 and 9.01
SEC Filing Form 8-K filed by Zynerba Pharmaceuticals, Inc. -- SEC File Number 211089272
+ My List
ABCL AbCellera Biologics Inc. - Common Shares 24.1% down 25.44% -1.34 + Medicine, Biology


Last highlighted: #ABCL SEC report: AbCellera Biologics Inc. Current report, items 8.01 and 9.01
SEC Filing Form 8-K filed by AbCellera Biologics Inc. -- SEC File Number 211088168
+ My List
ADAG Adagene Inc. - ADS, each representing 1.25 ordinary shares -0.27% -0.27% 0 + Medicine, Biology


Last highlighted: $ADAG 6-K Adagene (7 Jul, 7:52am) 📰 Adagene Announces Authorization of Share Repurchase Program up to US$20 Million https://t.co/QHy8NXROk9 #ADAG #6K #Adagene #News
+ My List
BCTX BriaCell Therapeutics Corp. - Common Shares 5.31% down 7.41% -2.1 + Cancer fight, Immunology, Medicine, Disease: Oncology


Last highlighted: #BCTX SEC report: BriaCell Therapeutics Corp. Report of foreign issuer [Rules 13a-16 and 15d-16]
SEC Filing Form 6-K filed by BriaCell Therapeutics Corp. -- SEC File Number 211182540
+ My List
BOLT Bolt Biotherapeutics, Inc. - Common Stock -9.19% -9.19% 0 + Immunology, Cancer fight, Disease: Oncology, Medicine

+ My List
CLOV Clover Health Investments, Corp. - Class A Common stock -6.89% up -7.77% 0.88 + Medicine, Medicare

+ My List
CLOVW Clover Health Investments, Corp. - Warrants 15.84% 15.84% 0 + Medicine, Medicare

+ My List
CLVR Clever Leaves Holdings Inc. - Common Shares -0.21% down 7.45% -7.66 + Medicine, Healthcare, Cannabis, Pharmaceutical

+ My List
CLVRW Clever Leaves Holdings Inc. - Warrant 8.26% 8.26% 0 + Medicine, Cannabis, Pharmaceutical , Healthcare

+ My List
DBTX Decibel Therapeutics, Inc. - Common Stock 7.21% 7.21% 0 + Disease: Ear/Nose, Medicine


Last highlighted: $DBTX 8-K Decibel Therapeutics (3 Jun, 4:21pm) 📰 Departure of Directors or Certain Officers; Election of Directors https://t.co/jFnGr8t4Eg #DBTX #8K #DecibelTherapeutics #News
+ My List
ENVB Enveric Biosciences, Inc. - Common Stock -10.24% down -4.78% -5.46 + Biotechnology, Cancer fight, Medicine, Cannabis, Disease: Oncology


Last highlighted: #ENVB SEC report: Enveric Biosciences, Inc. Notice of Effectiveness
SEC Filing Form EFFECT filed by Enveric Biosciences, Inc. -- SEC File Number 211084155
+ My List
EVAX Evaxion Biotech A/S - American Depositary Share -7.95% -7.95% 0 + Cancer fight, Disease: Oncology, Immunology, Medicine, Biotechnology, Biology


Last highlighted: #EVAX SEC report: Evaxion Biotech A/S Report of foreign issuer [Rules 13a-16 and 15d-16]
SEC Filing Form 6-K filed by Evaxion Biotech A/S -- SEC File Number 211078935
+ My List
FDMT 4D Molecular Therapeutics, Inc. - Common Stock 7.33% 7.33% 0 + Medicine, Gene and cell, Disease: Eye

+ My List
FSTX F-star Therapeutics, Inc. - Common Stock 1.05% down 12.63% -11.58 + Immunology, Medicine, Cancer fight, Disease: Oncology


Last highlighted: #FSTX SEC report: F-star Therapeutics, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by F-star Therapeutics, Inc. -- SEC File Number
+ My List
GBS GBS Inc. - Common Stock 6.45% down 8.5% -2.05 + Medicine, Biotechnology

+ My List
GTBP GT Biopharma, Inc. - Common Stock -9.77% down -7.91% -1.86 + Biopharma, Medicine, Disease: Oncology, Immunology, Cancer fight


Last highlighted: #GTBP SEC report: GT Biopharma, Inc. Notification of inability to timely file Form 10-Q or 10-QSB
SEC Filing Form NT 10-Q filed by GT Biopharma, Inc. -- SEC File Number 211181131
+ My List
INM InMed Pharmaceuticals Inc. - Common Shares -4.23% up -8.45% 4.22 + Country: Canada, Pharmaceutical , Medicine, Cannabinoid-based

+ My List
KMPH KemPharm, Inc. - Common Stock -12.27% down -12.08% -0.19 + Medicine, Pharmaceutical


Last highlighted: #KMPH SEC report: KEMPHARM, INC Current report, items 8.01 and 9.01
SEC Filing Form 8-K filed by KEMPHARM, INC -- SEC File Number 211102850
+ My List
LABP Landos Biopharma, Inc. - Common Stock 8.39% 8.39% 0 + Biopharma, Medicine

+ My List
LEXX Lexaria Bioscience Corp. - Common Stock 6.71% down 7.38% -0.67 + Biopharma, Medicine, Cannabinoid-based


Last highlighted: #LEXX SEC report: Lexaria Bioscience Corp. Current report, item 8.01
+ My List
LFMD LifeMD, Inc. - Common Stock 6.26% down 7.6% -1.34 + Healthcare, Medicare, Medicine


Last highlighted: #LFMD SEC report: LifeMD, Inc. Notice of Effectiveness
SEC Filing Form EFFECT filed by LifeMD, Inc. -- SEC File Number 211137767
+ My List
LGVN Longeveron Inc. - common stock -2.67% up -8% 5.33 + Biotechnology, Medicine, Gene and cell, Disease: Neurology/Alzheimer/Parkinson's

+ My List
LHDX Lucira Health, Inc. - Common Stock -2.11% up -12.41% 10.3 + Healthcare, Medicine, Disease: Infectious, RNA

+ My List
LIXT Lixte Biotechnology Holdings, Inc. - Common Stock 1.78% up -7.41% 9.19 + Biotechnology, Cancer fight, Disease: Oncology, Medicine


Last highlighted: #LIXT SEC report: LIXTE BIOTECHNOLOGY HOLDINGS, INC. Current report, item 5.07
SEC Filing Form 8-K filed by LIXTE BIOTECHNOLOGY HOLDINGS, INC. -- SEC File Number 211083663
+ My List
NEXI NexImmune, Inc. - Common Stock 8.96% 8.96% 0 + Medicine, Immunology


Last highlighted: A Form 10-Q [Quarterly Report] filing has been made with the SEC: $NEXI #NexImmune, Inc. #NexImmune, Inc https://t.co/SsyxY2SUAE
+ My List
NVOS Novo Integrated Sciences, Inc. - Common Stock 11.67% up 5.56% 6.11 + Healthcare, Medicine


Last highlighted: A Form 8-K [Press/News Current Report] filing has been made with the SEC: $NVOS $NVOSD Novo Integrated Sciences, Inc https://t.co/jDv4l739RN
+ My List
OCX OncoCyte Corporation - Common Stock 7.27% up 6.52% 0.75 + Cancer fight, Diagnosing, Medicine


Last highlighted: #OCX SEC report: OncoCyte Corp Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by OncoCyte Corp -- SEC File Number 211160996
+ My List
PHVS Pharvaris N.V. - Ordinary Shares 4.13% 4.13% 0 + Medicine, Pharmaceutical


Last highlighted: $PHVS 📜 SEC Form 6-K filed by Pharvaris N.V. https://t.co/Ra28QDTJZ3 15s delayed.
+ My List
RXDX Prometheus Biosciences, Inc. - Common Stock 7.7% down 8.02% -0.32 + Biotechnology, Medicine, Diagnosing, Immunology

+ My List
SBTX Silverback Therapeutics, Inc. - Common Stock -18.27% down -16.53% -1.74 + Cancer fight, Disease: Oncology, Disease: Infectious, Medicine

+ My List
SCPS Scopus BioPharma Inc. - Common Stock 3.12% down 8.41% -5.29 + Immunology, Cancer fight, Medicine, Disease: Oncology, Biopharma


Last highlighted: Alert [Quarterly Report] / Form 10-Q filed with the SEC $SCPS Scopus BioPharma Inc. Scopus BioPharma Inc https://t.co/lmBK4v1IJB
+ My List
SEER Seer, Inc. - Class A Common Stock -10.66% -10.66% 0 + Medicine, Proteome

+ My List
SGTX Sigilon Therapeutics, Inc. - Common Stock 10.34% 10.34% 0 + Medicine


Last highlighted: #SGTX SEC report: Sigilon Therapeutics, Inc. Current report, items 8.01 and 9.01
SEC Filing Form 8-K filed by Sigilon Therapeutics, Inc. -- SEC File Number 211081667
+ My List
TVTX Travere Therapeutics, Inc. - Common Stock 7.5% down 8.62% -1.12 + Biopharma, Medicine

+ My List
VINC Vincerx Pharma, Inc. - Common Stock 7.98% 7.98% 0 + Biopharma, Medicine, Life Sciences

+ My List
VOR Vor Biopharma Inc. - Common Stock 7.18% up 4.98% 2.2 + Biopharma, Medicine, Cancer fight, Disease: Oncology

+ My List
VRDN Viridian Therapeutics, Inc. - Common Stock 0.00% 0 + Disease: Eye , Medicine, Biotechnology


Last highlighted: $VRDN 8-K/A Viridian Therapeutics (15 Jun, 5:30pm) 📰 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year (amendment) https://t.co/Ot2kOEW3mb #VRDN #8KA #ViridianTherapeutics #News
+ My List
VRPX Virpax Pharmaceuticals, Inc. - Common Stock -4.03% up -30.51% 26.48 + Pharmaceutical , Medicine

+ My List
VSPR Vesper Healthcare Acquisition Corp. - Class A Common Stock -5.38% -5.38% 0 + Acquisitions/Investing, Medicine, Pharmaceutical , Healthcare

+ My List
VVOS Vivos Therapeutics, Inc. - Common Stock -0.83% up -9.62% 8.79 + Medicine, Sleeping, Airway/Apnea


Last highlighted: #VVOS SEC report: Vivos Therapeutics, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Vivos Therapeutics, Inc. -- SEC File Number
+ My List
IKNA Ikena Oncology, Inc. - Common Stock 10.27% 10.27% 0 + Cancer fight, Disease: Oncology, Medicine

+ My List
LVTX LAVA Therapeutics N.V. - Ordinary Shares -7.92% down -3.44% -4.48 + T cell-based, Cancer fight, Medicine, Disease: Oncology

+ My List
OLK Olink Holding AB (publ) - American Depositary Shares -7.02% down -6.64% -0.38 + Biology, Biopharma, Medicine, Country: Sweden


Last highlighted: #OLK SEC report: Olink Holding AB Report of foreign issuer [Rules 13a-16 and 15d-16]
SEC Filing Form 6-K filed by Olink Holding AB -- SEC File Number 211161931
+ My List
UPC Universe Pharmaceuticals Inc - Ordinary Shares 8.41% down 10.18% -1.77 + Country: China, Pharmaceutical , Medicine

+ My List


We do not provide financial advice. All displayed data is the result of experiments, and a subjective assessment. All decisions that will be made based on this data are made at your own risk. Thank you for understanding.